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OCTOMOM AND MULTI-FETAL PREGNANCIES: WHY
FEDERAL LEGISLATION SHOULD REQUIRE INSURERS TO
COVER IN VITRO FERTILIZATION
CAMILLE M. DAVIDSON*
ABSTRACT
On January 26, 2009, Nadya Suleman, dubbed Octomom by
the media, delivered octuplets after using in vitro fertilization. The
same day, Congressman Anthony Weiner of New York introduced
the Family Building Act of 2009 in the United States House of
Representatives—a federal mandate requiring insurers to provide
coverage for in vitro fertilization.1 The octuplets are no longer head-
line news, but issues associated with in vitro fertilization are still
newsworthy. In this paper I propose that Congress should take a
serious look at the Family Building Act of 2009. After addressing
some additional issues, Congress should pass legislation mandating
that insurers provide coverage for in vitro fertilization. Such legisla-
tion will have the effect of reducing the number of multi-fetal preg-
nancies and preterm births, as well as the costs and risks associated
with such pregnancies and births. 
Although in vitro fertilization is used to treat infertility, it has
replaced one problem (the inability to procreate) with a more serious
problem (multi-fetal pregnancies). This problem exists largely because
the fertility industry is not regulated. While the American Society of
Reproductive Medicine (ASRM)and the Society for Reproductive
Technology (SART) have issued permissive industry guidelines,
there is no serious consequence to the physician or clinic that ignores
those guidelines. As in vitro fertilization is expensive and largely
funded with out-of-pocket monies, patients and their physicians are
inclined to transfer more than one embryo for implantation during
* Assistant Professor, Charlotte School of Law. BBA magna cum laude Millsaps
College, J.D. Georgetown University Law Center. The author thanks Joan Krause,
Professor of Law University of North Carolina at Chapel Hill, and Judith Daar,
Professor of Law Whittier University, for encouraging her to join the discussion about
reproductive technology; Ruqaiijah Yearby, Associate Professor University at Buffalo
School of Law, and the Northeast People of Color Scholarship Conference participants
for comments on drafts of this paper; and Elizabeth A. Grymes, Charlotte School of Law
class of 2010, Stratford N. Kiger, Charlotte School of Law class of 2010, and her colleagues
at the Charlotte School of Law.
1. H.R. 697, 111th Cong. (1st Sess. 2009). The Act requires coverage for assisted
reproductive technologies. In vitro fertilization is the most common assisted reproductive
technology.
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each cycle of in vitro fertilization. They do so in order to increase the
chances of a “successful” pregnancy and maximize a patient’s use of
funds. As a result, women who undergo in vitro fertilization often
have more than one baby at a time.
Moreover, the only federal law that regulates the industry—the
Fertility Clinic Success Rate and Certification Act—also encourages
multiple embryo transfers by requiring physicians and clinics to re-
port their pregnancy success rates each year. A successful pregnancy
is one that results in a live birth—regardless of how many children.
This encourages physicians to transfer multiple embryos to increase
their chances of a successful pregnancy so that they can attract addi-
tional consumers. Because the human uterus is designed to carry only
one baby at a time, multi-fetal pregnancies are risky and usually re-
sult in preterm babies. The children often have long-term health and
other needs. This is a public health concern.
The Family Building Act would help regulate the largely unregu-
lated fertility industry. If passed, women and their physicians would
be inclined to transfer fewer embryos for implantation during a cycle
of in vitro fertilization because an unsuccessful pregnancy would not
mean the loss of out-of-pocket dollars. A patient would be more will-
ing to try again if insurance covered the procedure. Furthermore,
physician reimbursement rates could be tied to the industry guide-
lines. A federal mandate requiring insurers to cover in vitro fertil-
ization would strengthen the industry guidelines without a need for
an additional regulatory industry. An insurance mandate will reduce
the incidence of multi-fetal pregnancies, the largest problem associ-
ated with in vitro fertilization, and ultimately increase the incidence
of healthy single-baby pregnancies.
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CONCLUSION
INTRODUCTION
In January of 2009, Nadya Suleman delivered eight babies at
the Kaiser Permanente Medical Center in Bellflower, California.2
The media excitedly awaited details as to who delivered the latest
octuplets.3 Soon, the excitement turned to anger and judgment as
the following information came to light:
2. Ashley Surdin, Octuplet Mother Also Gives Birth to Ethical Debate, WASH. POST,
Feb. 4, 2009, at C1.
3. Id. at C8.
138 WILLIAM & MARY JOURNAL OF WOMEN AND THE LAW                  [Vol. 17:135
• The mother was identified as a thirty-three-year-old
single mother who already had six children under the
age of seven.4
• The mother received some public assistance for at least
two of her older children.5
• The mother was unemployed with no visible means of
income.6
• The mother lived with her parents, who were also in
financial trouble.7
• The mother used in vitro fertilization in each of her
pregnancies.8
• The mother’s physician transferred six cryopreserved
embryos for implantation, and they resulted in eight
babies.9
The media dubbed Ms. Suleman “Octomom,” and several pundits
offered solutions to the Octomom problem. Such solutions included
the following:
• Remove the babies from Ms. Suleman. She cannot nur-
ture them and care for them because she has no hus-
band and no money.10
• Bring charges against the physician for transferring six
embryos for implantation.11
4. Id. at C1.
5. Octuplets’ Mom On Welfare, Spokesman Confirms, FOXNEWS.COM, Feb. 10, 2009,
http://www.foxnews.com/story/0,2933,490269,00.html [hereinafter Octuplets’ Mom on
Welfare].
6. Jessica Garrison et al., Octuplets’ Birth Spawns Outrage from Public, L.A. TIMES,
Feb. 7, 2009, at B1, available at http://articles.latimes.com/2009/feb/07/local/me-octuplets7.
7. Id.
8. Octuplets’ Mom On Welfare, supra note 5.
9. Garrison et al., supra note 6.
10. See Castina, Nadya Suleman Child Protective Services Complaint (Child Abuse
Claim), POPCRUNCH.COM (Feb. 7, 2009), http://www.popcrunch.com/nadya-suleman-child
-protective-services-complaint-child-abuse-claim (stating that Dr. Carole Lieberman, “a
Los Angeles-area psychiatrist[,] has filed a complaint with . . . Child Protective Services
accusing controversial Nadya Suleman of child abuse and urging CPS to step in and re-
move the serial mommy’s newborn octuplets due to Suleman’s ‘inability to properly care
for her 14 children’ ”).
11. Pamela Madsen, Michael Kamrava, MD is Given the Boot From the American
Society for Reproductive Medicine, THE FERTILITY ADVOC. (Oct. 19, 2009), http://www
.thefertilityadvocate.com/?p=1798.
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• Create a regulatory agency to put limits on the number
of embryos that a physician may transfer, and regulate
cryopreserved embryos.12
• Mandate insurance coverage for in vitro fertilization.13
Octomom and her babies are no longer headline news. The
issues raised as a result of the saga, however, are still newsworthy.
Before the single unemployed Octomom gave birth to her eight
babies, the media celebrated other multi-fetal pregnancies and re-
warded the parents and children of these “miracle births” with en-
dorsements and television shows.14 Octomom’s saga, however, has
helped the general population understand the serious side effects
of multi-fetal pregnancies.15 The largest risk factor of multi-fetal
pregnancies is pre-term delivery and the long-term health needs and
developmental delays associated with such preterm babies. The
March of Dimes has recognized not only that preterm labor and
delivery is a serious public health issue that must be addressed, but
also that the rate of such births has increased thirty-six percent over
the last twenty-five years.16
The impact of such multi-fetal pregnancies does not just affect
the mother and her children; it affects all of society. In the case of
extreme multi-fetal pregnancies like Octomom’s pregnancy, hospitals
are generally not able to recoup the costs associated with the preg-
nancy and delivery of the resulting babies.17 Even in the case of
12. Bruce Patsner, The Octuplets: A Medical Mistake Needing More Regulation?, ON
THE EDGES OF SCI. AND L. (Feb. 17, 2009, 11:52 AM), http://blogs.kentlaw.edu/islat/
2009/02/the-octuplets-a-medical-mistake-needing-more-regulation.html.
13. John Zhang, Pass Legislation to Increase Insurance for In Vitro Fertilization, THE
HILL (June 22, 2009, 1:35 PM), http://thehill.com/opinion/op-ed/47123-pass-legislation -
to-increase-insurance-for-in-vitro-fertilization.
14. See, e.g., Jennifer Leahy, Famous Octuplets Reach Milestone, HOUS. CHRON.,
Dec. 21, 2008, at B4, available at http://www.chron.com/disp/story.mpl/moms/6175553
.html (discussing the tenth birthday of the surviving seven Chukwu octuplets); Stephanie
Woodard, The Septuplets Turn 10!, LADIES’ HOME J., Dec. 2007, http://www.lhj.com/style/
covers/the-septuplets-turn-10/ (discussing the tenth birthday of the McCaughey septuplets).
15. The reasons why Octomom was vilified are subjects for another paper. Unlike
famous moms of multiples, Octomom was a single, non-Christian, woman of color.
16. MARCH OF DIMES, WHITE PAPER ON PRETERM BIRTH: THE GLOBAL AND REGIONAL
TOLL 3 (2009), available at http://www.nann.org/pdf/09marchofdimes_whitepaper.pdf.
17. Robert Stillman, How to Promote Single Embryo Transfers, N.Y. TIMES ROOM
FOR DEBATE BLOG (Oct. 11, 2009, 3:00 PM), http://roomfordebate.blogs.nytimes.com/
200910/11/the-trouble-with-twin-births/. As a “reproductive endocrinologist and medical
director of Shady Grove Fertility Center in Rockville, Md.” and a past board member of the
American Society for Reproductive Medicine, Stillman stated that:
Between 1996 and 2007, following professional guidelines and improved clin-
ical outcomes, we saw an 87 percent decrease in triplet and quadruplet preg-
nancies as the average number of embryos transferred steadily dropped and
while the number of I.V.F. cycles and live births increased.
Id.
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twins and triplets, multi-fetal pregnancies tend to result in prema-
ture births. Such pregnancies and deliveries are costly and risky—
requiring additional medical professionals and neonatal intensive
care units that are not required of healthy single pregnancies. In
addition, as a result of being born underweight and underdeveloped,
many of the babies have long-term physical or mental disabilities.18
Treatment for such disabilities is often covered through insurance
or social programs such as Medicaid. Thus, all of society bears the
costs for multi-fetal pregnancies through either increased insurance
premiums or taxpayer funded programs.
Though preterm birth is known to be one of the largest neonatal
health issues in the United States, the focus on curing the issue has
primarily been directed at prenatal care for lower income women.19
For example, the recently passed Patient Protection and Affordable
Care Act provides grants for states and other entities “to develop
and implement evidence-based maternal, infant and early childhood
visitation models.” 20 These visitation programs target at-risk “com-
munities with concentrations of premature birth, low-birth weight
infants, and infant mortality, including infant death due to neglect,
or other indicators of at-risk prenatal, maternal, newborn, or child
health.” 21 In actuality, more than one-third of preterm births are a
result of fertility treatments.22 Thus, it is not simply an issue for at-
risk communities. Because multiple embryo transfers result in mul-
tiple babies, the rate of multi-fetal pregnancies is significantly higher
for women who undergo fertility treatment than those who conceive
naturally.23 While the incidence of multi-fetal pregnancies “is one
pair per 90 live births” with natural conception, such rate for women
who successfully undergo fertility treatments is about one in three.24
Thanks to the Octomom saga, it is now widely known that the
three billion dollar fertility industry is largely unregulated.25 Though
18. See Mark I. Evans, The Problem Is the Cost, N.Y. TIMES ROOM FOR DEBATE BLOG
(Oct. 11, 2009, 3:00 PM), http://roomfordebate.blogs.nytimes.com/2009/10/11/the-trouble
-with-twin-births/ (discussing the increased risk of complications with multiples).
19. Mike Stobbe, Premature Births Worsen US Infant Death Rate, MSNBC.COM, NOV. 3,
2009, http://www.msnbc.com/id/33604403/ns/health-kids_and_parenting/.
20. Health Care Reform, NAT’L FED. OF FAMILIES FOR CHILDREN’S MENTAL HEALTH,
http://www.ffcmh.org/what-we-do/policy/health-care-reform/ (last visited Nov. 22, 2010);
see also Patient Protection and Affordable Care Act, Pub. L. No. 111-148, § 2951, 124
Stat. 119 (2010) (detailing provisions for such grants).
21. Id. § 2951(b)(1)(A)(i).
22. Stobbe, supra note 19.
23. See Sarah Bernard & Hugo Lindgren, Twins—The High Cost of Multiple Births,
NYMAG.COM June 4, 2006, http://nymag.com/news/features/17205/index1.html#ixzz0
XQRdbRV7. In vitro fertilization disproportionately results in more pregnancies of twins,
triplets, or more than does natural conception.
24. Id.
25. See Cate Vojdik, Octuplets: The Cost of Making Babies, AC360 BLOG (Feb. 2,
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Octomom and her physician have suffered criticism for the large
number of embryos transferred for implantation during a cycle of in
vitro fertilization and failure to follow industry guidelines, statistics
suggest that most fertility clinics do not follow such industry guide-
lines.26 Furthermore, there are no real penalties for physicians who
do not follow such guidelines.27
On the same day that Octomom delivered her babies, Congress-
man Anthony Weiner introduced the Family Building Act of 2009 in
the House of Representatives.28 Senator Kirsten Gillibrand introduced
similar legislation in the Senate later that year.29 The companion bills
require insurers to provide coverage for in vitro fertilization and other
assisted reproductive technologies. I suggest that Congress should
take a serious look at the legislation. This bill should not languish in
committee without the benefit of hearings and a markup.30
A federal mandate requiring insurers to cover in vitro fertiliza-
tion will reduce multi-fetal pregnancies and lower the rate of preterm
births.31 Society will benefit from healthy single-birth pregnancies,
and there will probably not be increased costs for insurers. Here is
why: in vitro fertilization is a costly out-of-pocket procedure. With a
success rate of approximately twenty-seven percent, women and their
physicians may maximize their chances for a successful pregnancy
by transferring multiple embryos for implantation.32 Sadly, such
multiple embryos often result in multi-fetal pregnancies. The fed-
eral mandate requiring insurers to provide coverage for the proce-
dure would remove the primary incentive for patients to request or
physicians to offer to transfer multiple embryos for implantation—
money, or lack of money.
2009, 3:42 PM EST), http://ac360.blogs.cnn.com/2009/02/02/octuplets-the-cost-of -making-
babies/ (according to Deborah Spar, a former Harvard business professor, in her book
The Baby Business: How Money, Science, and Polities Drive the Commerce of Conception).
26. See Stephanie Nano, Few Fertility Clinics Follow Embryo Guidelines, S.F. CHRON.,
(Feb. 21, 2009), http://articles.sfgate.com/2009-02-21/news/17189772_1_two-embryos-
fertility-clinics-success-rates (noting “[f]ewer than 20 percent of U.S. clinics follow
professional guidelines on how many embryos should be implanted”).
27. Patsner, supra note 12.
28. H.R. 697, 111th Cong. (1st Sess. 2009).
29. S. 1258, 111th Cong. (1st Sess. 2009).
30. A markup allows amendments to the introduced bill to be introduced at a committee
meeting. Kevin M. McDonald, Don’t Tread on Me: Faster Than a Tire Blowout, Congress
Passes Wide-Sweeping Legislation That Treads on the Thirty-Five Year Old Motor Vehicle
Safety Act, 49 BUFF. L. REV. 1163, 1181 n.77 (2001).
31. A federal mandate requiring insurers to provide coverage for in vitro fertilization
may not have prevented Octomom’s strange saga. See Darshak Sanghavi, Pregnant Pause:
Who Should Pay for In Vitro Fertilization?, SLATE (Feb. 13, 2009), http://www.slate.com/
id/2211151/ (stating that Ms. Suleman collected $168,000 in disability payments in 1999,
which may have helped cover the procedure).
32. Zhang, supra note 13.
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A standard maternity benefits package includes coverage for labor
and delivery, regardless of the number of children. Those costs are sig-
nificantly higher for multi-fetal pregnancies than they are for single-
birth pregnancies. Additionally, insurers already cover the hidden
costs associated with in vitro fertilization when they cover the medi-
cally necessary treatments for twins, triplets, quadruplets or more.
As an insurance mandate will translate to fewer preterm babies, the
long-term health costs of preterm babies will diminish. Therefore,
the insurance mandate will not cost the insurance industry any more
money than it already spends for labor and delivery, as well as for the
long-term health needs of babies born in a multi-fetal pregnancy and
their mothers. Coverage for in vitro fertilization would be a shift in
costs and possibly lower long-term outlays for health insurance.
Part I of this paper identifies the problems associated with multi-
fetal pregnancies. There are long-term societal costs associated with
multi-fetal pregnancies and the resulting preterm births.33 Part II
looks at the current fertility industry guidelines and federal law.
The Association for Reproductive Medicine and the Society for Repro-
ductive Technology have industry guidelines that are to be used when
clinics do not have internal data. The guidelines are permissive and a
majority of clinics do not follow the guidelines. Currently, the Fertility
Clinic Success Rate and Certification Act is the only federal law that
regulates the fertility industry. The law was passed to assist con-
sumers as they identified successful clinics but encourages clinics
and physicians to transfer multiple embryos in order to be seen as
successful.
Part III addresses why federal legislation is necessary. Although
the medical community has defined infertility as a disease34 and the
Supreme Court has said that reproduction is a major life activity,35
the Supreme Court has stopped short of requiring insurers to pro-
vide coverage for in vitro fertilization under the Americans with
Disabilities Act36 or the Pregnancy Discrimination Act.37 Furthermore,
state regulation is inadequate. Only a few states have addressed the
issue and there is no uniformity. In addition, ERISA has a loophole
that exempts self-funded insurance plans from state mandates on
33. Id.
34. Frequently Asked Questions about Infertility, AM. SOC’Y FOR REPROD. MED., http://
www.asrm.org/awards/index.aspx?id=3012 [hereinafter Frequently Asked Questions]
(last visited Nov. 22, 2010).
35. Bragdon v. Abbott, 524 U.S. 624, 638 (1998).
36. Americans with Disabilities Act of 1990, Pub. L. No. 101-336, § 2, 104 Stat. 328
(1991) (codified at 42 U.S.C. §§ 12101-12213 (2000)).
37. Pregnancy Discrimination Act, Pub. L. No. 95-555, 92 Stat. 2076 (1978) (codified
at 42 U.S.C. § 2000e(k) (2000)).
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insurance providers. In Part IV, I recommend that Congress should
hold committee hearings and markups to strengthen the Family
Building Act and eventually pass federal legislation. It is my belief
that such legislation is needed and support for the legislation may be
garnered in the same way that support was garnered for the Drive
Through Maternity Benefits legislation that passed in the mid 1990s.
In the last Part, I conclude by acknowledging that a federal insurance
mandate will not answer all policy issues associated with in vitro
fertilization. In vitro fertilization is, however, the simplest and most
effective way to curb multi-fetal pregnancies and promote healthy
single-baby pregnancies.
I. UNDERSTANDING THE PROBLEM—THE HISTORY OF INFERTILITY
AND IN VITRO FERTILIZATION; WHY IS THERE A DARK SIDE TO THIS
MIRACLE PROCEDURE?
In vitro fertilization has helped many individuals realize their
dream of parenthood. But, there are often costs associated with such
parenthood. Also, while parents may think that a multi-fetal preg-
nancy, one that results in two, three or more children, is a success-
ful pregnancy, many serious health issues are associated with such
pregnancies. Such issues include “low birth weight, cerebral palsy,
blindness, hearing impairment, and cognitive delays.” 38 These “com-
plications associated with [in vitro fertilization] are often distanced
from the more glowing accounts about reproductive conception.” 39
A. “Be [F]ruitful, and [M]ultiply,” 40 but What if I Can’t?
In the Garden of Eden, God commanded Adam and Eve and all of
the animals to “[b]e fruitful, and multiply.”41 Unfortunately, all human
beings do not have the natural ability to do so. Such individuals are
deemed to be infertile. Infertility is the inability to multiply after con-
tinued unprotected intercourse.42 It occurs when pregnancy and live
birth cannot be achieved because either the male or female repro-
ductive system is not working properly.43 Various entities define the
requisite period of time in different ways. For example, “[t]he World
Health Organization defines this period of time as two years, while
38. Michele Goodwin, Assisted Reproductive Technology and the Double Bind: The
Illusory Choice of Motherhood, 9 J. GENDER RACE & JUST. 1, 3 (2005).
39. Id. at 26-27.
40. Genesis 1:28.
41. Id.
42. THE STAFF OF RESOLVE WITH DIANE ARONSON, RESOLVING INFERTILITY 5 (Diane
N. Clapp & Margaret R. Hollister eds., 1999).
43. Id. at 63.
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the standard medical definition is twelve months, or at least three
consecutive miscarriages or stillbirths.” 44 The American Society for
Reproductive Medicine (ASRM) and Society for Assisted Reproductive
Technology (SART) define this period as twelve months for women
thirty-five and younger, and six months for women over the age of
thirty-five.45
Even though most people often think of infertility as a “woman
problem,” the condition affects men and women at almost equal
rates.46 Female infertility is often caused by blocked fallopian tubes
resulting from endometriosis or other such conditions. Other causes
include ovulation disorders or disorders of the uterus or cervix.47 Low
sperm production, no sperm production, and blocked passage of sperm
are some of the causes of male infertility.48 Additionally, fertility de-
clines with age in both men and women.49 Although infertility has
been attributed to environmental toxins and poor nutrition,50 con-
ception to birth is a complicated process, and sometimes the causes
of infertility are unexplainable.
Generally speaking, the treatment for infertility is as follows:
When infertility has been diagnosed, eighty-five to ninety percent of
cases are treated using an infertility drug.51 Individuals can also turn
to surgery, such as laparoscopy, which may be used to treat female
structural problems.52 Intrauterine or artificial insemination, a non-
surgical procedure, is also an option, especially if there is a male
infertility issue.53 If these methods are ineffective, which is true for
44. Crystal Liu, Note, Restricting Access to Infertility Services: What is a Justified
Limitation on Reproductive Freedom? The Categorical Exclusion of Single Women and
Same-Sex Couples from Infertility Services and its Role in Defining What Constitutes
Justified and Unjustified Limitations on Reproductive Freedom, 10 MINN. J. L. SCI. & TECH.
291, 294 (2009) (citing EMILY JACKSON, REGULATING REPRODUCTION: LAW, TECHNOLOGY
AND AUTONOMY 162 (2001)).
45. Practice Committee of the American Society for Reproductive Medicine,
Definitions of Infertility and Recurrent Pregnancy Loss, 89 FERTILITY & STERILITY 1603, 1603
(2008) [hereinafter Definitions of Infertility and Recurrent Pregnancy Loss], available at
http: / /asrm.org /uploadedFi les /ASRM_Content/News_and_Publications
/Practice_Guidelines/ Committee_Opinions/Definitions_of_infertility_and_recurrent.pdf.
46. ARONSON, supra note 42, at 7 (“Infertility is a female problem in 40 percent of
cases, a male problem in 40 percent of cases, and a combined problem of the couple or
unexplained in 20 percent of cases.”).
47. Frequently Asked Questions, supra note 34.
48. Elizabeth A. Pendo, The Politics of Infertility: Recognizing Coverage Exclusions
as Discrimination, 11 CONN. INS. L.J. 293, 299 (2005).
49. ARONSON, supra note 42, at 14.
50. Lisa M. Kerr, Note, Can Money Buy Happiness? An Examination of the Coverage
of Infertility Services under HMO Contracts, 49 CASE W. RES. L. REV. 599, 605 (1999).
51. Pendo, supra note 48, at 299 (noting that “clomiphene and gonadtropins [are used]
to regulate ovulation and to return female or male hormones to normal levels”).
52. Id. (citing Bonny Gilbert, Infertility and the ADA: Health Insurance Coverage for
Infertility Treatment, 63 DEF. COUNS. J. 42, 43 (1996)).
53. Bonny Gilbert, Infertility and the ADA: Health Insurance Coverage for Infertility
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a small percentage of individuals, advanced reproductive technologies
(ARTs) are necessary. The Centers for Disease Control and Prevention
defines ART “as all treatments or procedures that involve the handling
of human eggs and sperm for the purpose of helping a woman become
pregnant.” 54 In vitro fertilization is the most common ART.55 Approxi-
mately one in eighty babies is a result of in vitro fertilization.56
B. The Evolution of In Vitro Fertilization
In vitro fertilization is a surgical procedure that helps women
with blocked or non-existent fallopian tubes achieve and sustain a
pregnancy.57 In the most basic form, in vitro fertilization is a procedure
in which a woman’s eggs are fertilized with a man’s sperm58 and then
transferred “into the woman’s uterus for possible implantation.” 59
The procedure involves the need to stimulate a woman’s ovaries to pro-
duce eggs,60 and the egg retrieval process requires intravenous seda-
tion.61 Once retrieved, the eggs are graded and incubated before sperm
is added.62 The number of embryos transferred usually “depends on
[the] embryo quality and the woman’s age.” 63 Women can elect to
cryopreserve (freeze) the embryos that are not transferred.64 One
reason for cryopreservation is to have embryos already available if
the cycle is not successful.65
The “first test tube baby,” Louise Brown, was born in the United
Kingdom on July 25, 1978.66 Although much of the world celebrated
the new technology, there were critics who considered the procedure
to be an unethical and immoral medical experiment.67 Some even
Treatment, 63 DEF. COUNS. J. 42, 43 (1996).
54. ARONSON, supra note 42, at 175 (internal quotation marks omitted).
55. See id. (providing examples such as “gamete intrafallopian transfer (GIFT), zygote
intrafallopian transfer (ZIFT), embryo cryopreservation, egg or embryo donation, and gesta-
tional carriers”).
56. Sanghavi, supra note 31.
57. ARONSON, supra note 42, at 176.
58. Id. (noting that doctors today use a plastic dish rather than a glass dish; however,
in vitro literally means “in glass”).
59. Id.
60. Id. at 177 (asserting that there is a need “to increase the number of mature eggs
that can be retrieved”).
61. Id. at 179.
62. Id. at 180.
63. ARONSON, supra note 42, at 181.
64. Id. at 182.
65. EMILY JACKSON, REGULATING REPRODUCTION: LAW, TECHNOLOGY AND AUTONOMY
164 (2001).
66. Judith Woods, IVF: The Birth That Started a Revolution, TELEGRAPH.CO.UK,
July 21, 2008, http://www.telegraph.co.uk/health/women_shealth/3355633/ IVF-The-
birth-that-started-a-revolution.html.
67. Liu, supra note 44, at 315.
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likened the procedure to the atomic bomb.68 Even so, the procedure
allowed Louise’s infertile mother to experience pregnancy and child-
birth. Australia and the United States soon followed with their very
own test tube babies. Two in vitro pregnancies were documented live
in Australia in 1980.69 In December of 1981, Elizabeth Jordan Carr
was born in Virginia as a result of the new medical technology.70
More than thirty years have passed since the first live birth using
in vitro fertilization. The current state of in vitro fertilization has pro-
duced issues that are far more complex than those associated with
the birth of Louise Brown and Elizabeth Carr.71 Although many indi-
viduals can testify that in vitro fertilization has helped them realize
their dream of becoming parents, the unregulated fertility industry
has an unhealthy dark side. In vitro fertilization is an expensive pro-
cedure that most individuals fund with out-of-pocket dollars. Only a
few states have mandated insurance coverage for the procedure, and
all of those mandates have limitations.72 As a result of the expense,
physicians and patients are motivated to maximize a patient’s invest-
ment dollars and transfer multiple embryos for implantation. Such
transfers result in a higher incidence of twins, triplets, and even
higher order births.73 The unhealthy dark side of in vitro fertilization
occurs when a woman carries more than one child at a time. Such
pregnancies result in significant medical risks to the children and
mothers. Deaths, disabilities, and other long-term problems are often
overlooked as we celebrate the happy occasion of new babies.74
C. What is Wrong with Multi-Fetal Pregnancies?
Octomom’s babies were born nine weeks early and weighed be-
tween one and a half pounds and a little more than three pounds.75
68. Id. (“During the early 1970s when scientists were pursuing the possibility of IVF,
a British magazine wrote a cover story analogizing IVF to the atomic bomb.”).
69. IVF, BIOTECHNOLOGY ONLINE, http://www.biotechnologyonline.gov.au/human/ivf
.html (last visited Nov. 22, 2010).
70. David Rapp, America’s First Test-Tube Baby Turns 25, AMERICANHERITAGE .COM,
Dec. 28, 2006, http://www.americanheritage.com/articles/web/20061228-in-vitro-fertilization
-reproductive-technology-ivf-elizabeth-carr-howard-jones-georgeanna-jones.html.
71. Issues such as cloning are beyond the scope of this paper.
72. See State Mandated Insurance for Fertility Treatment, FERTILITY LIFELINES,
http://www.fertilitylifelines.com/payingfortreatment/state-mandatedinsurancelist.jsp (last
visited Nov. 22, 2010) (“Currently only 15 states have laws requiring insurance coverage
for infertility treatment.” These states are Arkansas, California, Connecticut, Hawaii,
Illinois, Louisiana, Maryland, Massachusetts, Montana, New Jersey, New York, Ohio,
Rhode Island, Texas, and West Virginia.).
73. Mark I. Evans, The Truth About Multiple Births, NEWSWEEK, Mar. 2, 2009, at 14.
74. Id.
75. Vojdik, supra note 25.
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Four dozen medical professionals helped ensure their safe arrival.76
A world record indeed, but it was not one to be celebrated. Each of
the babies required intensive care.77
In vitro fertilization is considered a treatment for infertility.
The procedure has, however, replaced one problem (inability to have
children) with a more severe problem (multi-fetal pregnancies). The
largest problem of multi-fetal pregnancies is that they result in the
preterm births of multiple babies. Although super multi-fetal preg-
nancies like Octomom’s are rare occurrences, twins, triplets, and qua-
druplets are not rare occurrences.78 The March of Dimes has stated
that fertility treatments have contributed to the significant increase
of preterm babies.79
Preterm labor and delivery is costly and dangerous to both a
mother and her children. Approximately 51% of twins and 91% of
triplets are born preterm, compared to 9.4% in single-birth pregnan-
cies.80 Approximately 14% of twins and 41% of triplets are born very
preterm, compared to 1.7% in single-birth pregnancies.81 The average
gestational age for twins is 34 to 36 weeks, for triplets is 32 to 34
weeks, and for quadruplets is 28 to 30 weeks.82 Physicians often do
not do the greatest job of explaining the risks associated with deliv-
ering more than one baby, including twins.83
Babies who are born prematurely have low birth weights, which
means that they have a greater risk of complications and even death.84
A mother may require more medical care during her pregnancy and
her children may require additional medical care during the pregnancy
76. Sanghavi, supra note 31.
77. See Vojdik, supra note 25 (noting that the babies were “underweight and under-
developed”).
78. Pamela Prindle Fierro, Twin and Multiple Birth Rate Statistics, ABOUT.COM,
http://multiples.about.com/od/funfacts/a/twinbirthrate.htm (last visited Nov. 22, 2010).
According to data collected in 2006, rates of quadruplets, quintuplets and other higher-
order births are on the decline, whereas the rate of live births in twin deliveries has more
than doubled since 1980.
79. Stephanie Saul, The Gift of Life, and Its Price, N.Y. TIMES, Oct. 11, 2009, at A1
(stating that “an increasing number of the newborns are twins, and they carry special
risks often overlooked”).
80. Greg R. Alexander et al., What Are the Fetal Growth Patterns of Singletons, Twins,
and Triplets in the United States?, 41 CLINICAL OBSTETRICS & GYNECOLOGY 115, 117 (1998).
81. Id.
82. Christopher J. De Jonge & Don P. Wolf, Embryo Number for Transfer Should Be
Regulated, 68 FERTILITY & STERILITY 784, 785 (1997).
83. See Christina Vienna, Comment to The Trouble with Twin Births, N.Y. TIMES ROOM
FOR DEBATE BLOG (Oct. 12, 2009, 6:27 PM), http://community.nytimes.com/comments/
roomfordebate.blogs.nytimes.com/2009/10/11/the-trouble-with-twin-births/ (commenting
that “[n]o one sat down and told us the risk of prematurity, and all the other worries that
came along with that”).
84. De Jonge & Wolf, supra note 82, at 785.
148 WILLIAM & MARY JOURNAL OF WOMEN AND THE LAW                  [Vol. 17:135
and at birth.85 Such babies may have long-term health needs and
developmental delays, which can also affect parents.86
According to a 2006 report of the Institute of Medicine, preterm
births cost the United States an average of approximately $51,000 per
infant or $26 billion.87 Most of the expense is associated with medical
care.88 In 2007, the average cost of an uncomplicated childbirth was
approximately $8,802.89 “In one study, the average hospital charge
for mother and infant was $9,845 for singletons, $37,947 for twins
($18,974 per baby), and $109,765 for triplets ($36,588 per baby).” 90
In addition to the costs for delivery, preterm babies born as a
result of a multi-fetal pregnancy generally require more medical
attention throughout their first year of life and are less healthy than
babies born as a result of a single birth. There is a greater risk of
death associated with low birth weight babies.91 Additionally, such
babies have a substantial need for care and often suffer long-term
damage, in spite of advances in medical care.92 The low birth weight
often means that the babies will have disabilities that require long-
term—and costly—medical treatment:93
The average cost of medical care for a premature or low birth-
weight baby for its first year of life is about $49,000, according
to a new report from the March of Dimes Foundation. By contrast,
a newborn without complications costs $4,551 for care in its first
year of life, the report said. Newborns with other kinds of com-
85. Saul, supra note 79, at 1.
86. Id.
87. Vojdik, supra note 25.
88. Id.
89. Margaret Denett, The Average Cost of Child Birth, EHOW, http://www.ehow.com
/facts_5391105_average-cost-child-birth.html (last visited Nov. 22, 2010).
According to a study by Thomson Healthcare for The March of Dimes, sub-
mitted in June 2007, the average vaginal childbirth cost $7,737 in 2004. . . .
The June 2007 study conducted for the March of Dimes says one-third of all
U.S. babies are born via Cesarean section, at an average cost of $10,958,
which is $3,000 more than vaginal births.
Id.
90. Carson Strong, Too Many Twins, Triplets, Quadruplets, and So On: A Call For
New Priorities, 31 J.L. MED. & ETHICS 272, 274 (2003). “These higher costs are due to a
number of factors, including an increase in cesarean sections, more ICU (intensive care
unit) admissions for the infants, and longer hospitalizations for the infants and mothers.”
Id. (citing T.L. Callahan et al., The Economic Impact of Multiple-Gestation Pregnancies
and the Contribution of Assisted-Reproduction Techniques to Their Incidence, 331 NEW.
ENG. J. MED. 244, 244-49 (1994)).
91. Barbara Luke & Louis G. Keith, The Contribution of Singletons, Twins and
Triplets to Low Birth Weight, Infant Mortality and Handicap in the United States, 37 J.
REPROD. MED., 661, 666 (1992).
92. Elizabeth Landau, Study: Average Preemie Costs $49,000 in First Year, CNN.COM
Mar. 17, 2009, http://www.cnn.com/2009/HEALTH/03/17/premature.babies/index.html.
93. Id.
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plications, such as congenital defects, have medical expenses of
$10,273 on average in the first year.94
One example of a long-term treatment cost for preterm babies
is the Synagis vaccine.95 Most preterm babies are at risk for RSV, a
severe respiratory virus. As a result of such diagnosis, the babies
require the Synagis vaccine. Each dose of the vaccine costs approxi-
mately $2,000, so the full treatment cost is approximately $8,000 to
$10,000.96 There are also greater frequencies of cardiovascular,
urogenital, and musculoskeletal defects in children born with the
assistance of in vitro fertilization than those born through natural
conception.97 There are significant long-term costs associated with
treating these defects.
Multi-fetal pregnancies encumber the parent as well as the child.
In addition to risks to the children, multi-fetal pregnancies also ad-
versely affect the mother. For example, mothers often suffer with
pregnancy risks such as gestational diabetes and preeclampsia.98
Additionally, parents of multiples often have medical and psycholog-
ical issues. Many are unprepared for the emotional challenges of
raising multiple children. A substantial amount of time is needed to
manage a household and care for multiple children. “[F]atigue and
stress arising from child care is almost universal for mothers of mul-
tiples. Research also shows a higher incidence of depression, alcohol
and drug abuse, and divorce among mothers with multiples.” 99
II. THE CURRENT STATE OF AFFAIRS—FEDERAL LAWS AND
FERTILITY INDUSTRY GUIDELINES
The United States has a higher incidence of preterm births
than other developed counties.100 Data from countries that provide
insurance coverage for in vitro fertilization shows that such countries
94. Id.
95. Synagis is a medication designed to protect high-risk babies and preemies from
RSV (respiratory syncytial virus). See Synagis (Palivizumab), http://www.synagis.com
(last visited Nov. 22, 2010).
96. This information was obtained in Author’s conversation with a pediatrician.
97. Jennifer L. Rosato, The Children of ART (Assisted Reproductive Technology):
Should the Law Protect Them From Harm?, 2004 UTAH L. REV. 57, 78 (2004).
98. Lars Noah, Assisted Reproductive Technologies and the Pitfalls of Unregulated
Biomedical Innovation, 55 FLA. L. REV. 603, 620 (2003). “ART procedures [also] raise a
variety of other safety concerns for the mother, ranging from acute and chronic side effects
associated with the use of fertility drugs . . . to complications involved in the harvesting
procedure, and higher rates of ectopic pregnancies.” Id. at 620-21.
99. Strong, supra note 90, at 274 (citations omitted).
100. Janet Tucker & William McGuire, ABC of Preterm Birth: Epidemiology of
Preterm Birth, 329 BMJ 675 (2004), available at http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC517653/.
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have lower rates of embryo implantation and lower rates of multi-
fetal pregnancies than the United States, where there is not manda-
tory insurance coverage.101 Because the United States relies on the
guidelines promulgated by ASRM and SART, an insurance mandate
would help strengthen those guidelines by giving physicians an in-
centive to follow them. Current data suggests that most fertility clinics
do not follow the industry guidelines.102 There is no incentive for them
to do so. In fact, the only federal law that regulates the fertility in-
dustry enables physicians to disregard the guidelines. That law, the
Fertility Clinic Success Rate and Certification Act of 1992,103 requires
clinics to report their success rates to the Centers for Disease Control.
Multi-fetal pregnancies count as successful pregnancies. Patients
use this information to assist them as they choose a clinic. As clinics
want to have a high success rate, physicians will often implant mul-
tiple embryos to increase the chances for success. After all, a success-
ful clinic will presumably attract new patients, and those satisfied
patients will refer others. Unfortunately, successful often means two,
three, or more babies.
A. Lack of Insurance Coverage for In Vitro Fertilization Increases
the Rate of Multi-Fetal Pregnancies
When first introduced, in vitro fertilization allowed childless
couples to become parents. Yet no one ever imagined that a huge
and dangerous downside to the procedure lurked—“multiplying” too
much. Within the time-span of three decades, we have gone from the
celebration of Louise and Elizabeth to the shock of Octomom.
The chance of a multi-fetal pregnancy is higher with in vitro
fertilization than with natural conception, and there is no incentive
for a physician to transfer fewer embryos per in vitro fertilization
cycle.104 Money is a motivating factor when it comes to the number of
embryos transferred for implantation during a cycle of in vitro fer-
tilization. Because many families often take out loans or second
mortgages to fund in vitro fertilization, patients request or physi-
cians offer to transfer two, three, or more embryos in order to maxi-
mize chances of a successful pregnancy.105 Multiple embryo transfers
101. In Vitro Fertilization: Doctors Perform More IVF Treatments, But Multiple Births
Decline, WOMEN’S HEALTH WKLY., Aug. 9, 2001, at 14-15.
102. Most Fertility Clinics Break the Rules, MSNBC.COM, Feb. 20, 2009, http://www
.msnbc.com/id/29305552/.
103. Fertility Clinic Success Rate and Certification Act of 1992, Pub. L. No. 102-493,
106 Stat. 3146 (codified at 42 U.S.C. § 263a-1 to -7 (2000)).
104. The reasons will be discussed in this paper.
105. See Stephanie Saul, Grievous Choice on Risky Path to Parenthood, N.Y. TIMES,
Oct. 11, 2009, at A1, A14 (stating that multi-fetal pregnancies may also result from the
use of a less effective fertility treatment, such as intrauterine insemination, when in vitro
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are the result of patients attempting to maximize their invest-
ments.106 The cost of one cycle of in vitro fertilization is approximately
$12,400.107 A successful pregnancy occurs only forty to fifty percent
of the time when a single embryo is transferred for implantation.108
“[E]ach attempt at [in vitro fertilization] is a financial gamble.”109
Success rates increase as the number of embryos increase. Physicians
want to please their patients by producing a successful pregnancy.
The happy patients then refer other clients to the physician and the
cycle continues.110 Sadly, a multi-fetal pregnancy is not necessarily
a successful pregnancy.
There are no federal laws that limit the number of embryos that
may be transferred for implantation during a cycle of in vitro fertil-
ization.111 The only federal law that regulates in vitro fertilization,
the Fertility Clinic Success Rate and Certification Act, may actually
encourage physicians to transfer multiple embryos for implanta-
tion.112 Furthermore, the American Society of Reproductive Medicine
(ASRM) and Society for Assisted Reproductive Technology (SART)
guidelines are not rigid mandates that impose penalties on physicians
who transfer more than one embryo.113
fertilization is not covered by insurance).
106. See Smeyler, Comment to The Trouble with Twin Births, N.Y. TIMES ROOM FOR
DEBATE BLOG (Oct. 12, 2009, 3:35 PM), http://community.nytimes.com/comments/room
fordebate.blogs.nytimes.com/2009/10/11/the-trouble-with-twin-births/.
We were counseled on the likelihood of multiples, issues related to that, and
provided a choice of 1-3 embryos being used. Given the cost and the reality
that we would likely only ever have one shot at child birth (our history include
[sic] 5 years of trying, which is not uncommon), we chose (key word here) to
use more than one embryo and had twins as a result.
Id.
107. Frequently Asked Questions, supra note 34. This amount includes lab screenings
for both parents, ultrasound and lab work, egg recovery, and embryo transfer. See Cost
of In Vitro Fertilization,LOVE TOKNOW, http://pregnancy.lovetoknow.com/wiki/Cost_of
_In_Vitro_Fertilization (last visited Nov. 22, 2010).
108. Sanghavi, supra note 31.
109. Goodwin, supra note 38, at 26 (citation omitted).
110. See, e.g., Saul, supra note 105, at A14 (stating that Jon and Kate Gosselin used
intrauterine insemination (IUI)). Additionally, some patients choose less effective methods
for fertility treatments because they are less costly than in vitro fertilization. Those preg-
nancies too often result in higher order multi-fetal pregnancies.
111. See Ronald Chester, Double Trouble: Legal Solutions to the Medical Problems of
Unconsented Sperm Harvesting and Drug-Induced Multiple Pregnancies, 44 ST. LOUIS
U. L.J. 451, 466 (2000) (noting that an attempt at such a law might lead to an outcry that
the government is trying to encroach on “a woman’s right to procreate”).
112. Karey Harwood, Harwood Follows up on Ethical Issues at Stake in the Octuplets
Case, UNC PRESS BLOG (Feb. 25, 2009, 6:18 PM), http://uncpressblog.com/2009/02/25/
harwood-follows-up/.
113. Jesse Reynolds, Preventing the Next Fertility Clinic Scandal, BIOETHICS FORUM
(Mar. 13, 2009), http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=3240&
biogid=140.
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After Octomom’s saga, some suggested that a regulatory agency
was necessary. While pontificating about the need for a regulatory
entity makes for great intellectual discussions, Americans often
shun such government intervention, and legislation would undoubt-
edly be extremely difficult to pass. Federally mandated insurance
coverage can, however, have a positive effect on reducing multi-fetal
pregnancies.
A federal mandate for insurers to cover in vitro fertilization
would provide the needed financial incentive for a physician to trans-
fer fewer embryos because, if the physician did transfer multiple
embryos, he or she would not otherwise be reimbursed by the insur-
ance carrier. Additionally, such a mandate would reduce the incentive
for a patient to request multiple embryos. Insurance coverage removes
the “financial gamble.”114 In states and countries with mandated
coverage for in vitro fertilization, there are lower embryo transfer
rates and fewer multi-fetal pregnancies.115 Unfortunately, few states
have mandates, and the fertility industry is often described as the
“Wild Wild West.”116 Federally mandated insurance coverage for
in vitro fertilization can help curtail the behaviors of patients and
physicians in this unregulated market.
B. The Fertility Clinic Success Rate and Certification Act
There is only one federal law that regulates in vitro fertilization,
the Fertility Clinic Success Rate and Certification Act of 1992.117 The
purpose of the Act was to help a consumer make informed choices
as she selects an appropriate fertility clinic.118 Unfortunately, the
Act is fundamentally flawed. According to the language of the Act,
the success of a fertility clinic is determined by the number of live
births the clinic “produces” each year; the Act requires fertility clinics
to report their success rates annually.119 The Centers for Disease
Control (CDC) compiles the data and publishes the success rates. It
also publishes the names of clinics that do not disclose their preg-
nancy success rates in accordance with the regulations.120
114. Goodwin, supra note 38, at 26.
115. Tarun Jain et al., Insurance Coverage and Outcomes of In Vitro Fertilization, 347
NEW ENG. J. MED. 661, 661, 664-66 (2002).
116. See Alexander N. Hecht, The Wild Wild West: Inadequate Regulation of Assisted
Reproductive Technology, 1 HOUS. J. HEALTH L. & POL’Y 227, 228-29 (2001) (citations
omitted) (noting that “[t]he near-absence of federal and state law combined with ineffective
and unheeded industry guidelines leads to a lawless free-for-all”).
117. Fertility Clinic Success Rate and Certification Act of 1992, Pub. L. No. 102-493,
106 Stat. 3146 (codified at 42 U.S.C. § 263a-1 to -7 (2000)).
118. Id.
119. Id.
120. Lyria Bennett Moses, Understanding Legal Responses to Technological Change:
The Example of In Vitro Fertilization, 6 MINN. J. L. SCI. & TECH. 505, 568, 593 (2005).
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Clinics use various treatment approaches in order to be seen as
successful. For example, a clinic with poor success results may be
inclined to transfer multiple embryos in order to maximize its chances
of a successful live birth.121 In the case of Octomom’s physician, a
look at data from the 2004 CDC Report shows that while the live birth
rate was the same as the national industry average, the average
number of embryos transferred was much higher than the industry
average.122 Octomom’s physician needed to transfer greater numbers
of embryos in order to keep his success rate at the industry average.
The Fertility Clinic Success Rate and Certification Act created
a vicious cycle. A clinic needs customers to be not only successful, but
to remain in business. A clinic also needs to show customers that it
has a high percentage of live births. The clinic is not motivated to
reduce the number of embryos transferred for fear of reducing the
number of live births. When “[t]he profitability of a particular practice
depends on its success, which in turn is measured by the number of
pregnancies and live births,”123 the end result is a large incidence of
multi-fetal pregnancies.124 Individuals who are paying for the proce-
dure using out-of-pocket funds have no incentive to reverse the cycle.
Because the industry is unregulated, it is not uncommon for
clinics to offer unorthodox methods to attract patients. A search on
the internet uncovered money-back guarantees to patients,125 dis-
counts for prepayment of multiple cycles,126 and loan programs.127
“In a perfect market, consumers [would]” carefully research their
options. They “[would] spend resources to obtain information in pro-
portion to the perceived benefit of that information.”128 When a
physician has slick marketing practices, however, patients may not
carefully analyze their options.129
121. Terrence Lee, Octuplets Doctor May Have Been Lulled by Past Poor Success,
FERTILITY FILE BLOG (Feb. 9, 2009), http://fertilityfile.com/2009/02/09/octuplets-doctor
-may-have-been-lulled-by-past-poor-success/.
122. Id. (The physician reported outcomes in 2004 and 2006, but not in 2005. In 2004,
for women under 35, his average number of embryos transferred was 3.8 as compared
to the national average of 2.5.).
123. Rosato, supra note 97, at 73 (citations omitted).
124. Josephine Johnston, Judging Octomom, HASTINGS CENTER REP., May-June 2009,
at 23, 23.
125. See, e.g., IVF Pricing Plans, ADVANCED FERTILITY CTR. OF CHI., http://www
.advancedfertility.com/ivfpr100.htm (last visited Nov. 22, 2010) (providing a 100%
guarantee plan).
126. See, e.g., Fertility Treatment Costs, REPROD. CARE CTR., http://www.fertilitydr.com/
fertility-treatment-cost.html (last visited Nov. 22, 2010) (noting discounts for prepayment
of multiple IVF cycles).
127. See, e.g., Loan Programs, HOUS. IVF, http://www.houstonivf.net/BecomingAPatient/
FinancingInfertility.aspx (last visited Nov. 22, 2010) (listing loan programs for IVF).
128. Moses, supra note 120, at 568.
129. Id.
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Insurance coverage can counter the vicious cycle that results from
the Fertility Clinic Success Rate and Certification Act. Physicians will
not be inclined to transfer multiple embryos if their insurance carrier
will not reimburse them. When a patient can rely on insurance rather
than out-of-pocket funds, she is more inclined to accept the physi-
cian’s decision to transfer fewer embryos because she can try again
if the cycle is unsuccessful. The additional attempt is not so daunting
if the individual patient does not have to finance the procedure with
out-of-pocket funds. If insurance covered in vitro fertilization, neither
physician nor patient would have an incentive for wayward conduct,
and the rate of multi-fetal pregnancies would decline.130
Clinics need patients to stay in business. More individuals would
probably utilize the procedure if it were covered by insurance.131 This
would create more business for physicians and reduce the need for
money-back guarantees and other such practices.132 In addition, the
insurance industry could help ensure that fees are not out of the ordi-
nary. Still another reason for mandating insurance coverage is that
many women do not have access to the procedure. Although infertility
affects women and men of all races and socioeconomic groups,
Currently, infertility treatments are typically used by better-
educated, upper-middle class white professional women. This is
a direct result of the high costs and lack of insurance coverage
for these procedures. For example, seventy-five percent of low-
income women in need of infertility services, a disproportionate
number of whom are African-American, do not have access to
those services.133
C. ASRM and SART Guidelines are Limited and Too Flexible
Several of Octomom’s critics suggested that her physician, Dr.
Michael Kamrava, should be punished for transferring six embryos
for implantation. Some suggested that legal action was warranted
because he did not follow industry standards.134 But, Dr. Kamrava
130. Also, insurance coverage would allow younger women, women of color, and less
economically-advantaged women to have the same access to the procedure. See Judith
F. Daar, Accessing Reproductive Technologies: Invisible Barriers, Indelible Harms, 23
BERKELEY J. GENDER L. & JUST. 18, 36-37 (2008).
131. Dorothy Roberts, Racial Disparity in Reproductive Technologies, CHI. TRIB., Jan. 29,
1998, at 19N (stating that, although infertility affects all races and classes, assisted repro-
ductive technologies “are used primarily by white people, in particular by affluent and
highly educated women”).
132. Stacey A. Huse, The Need for Regulation in the Fertility Industry, 35 U. LOUISVILLE
J. FAM. L. 555, 572 (1996-97).
133. Kerr, supra note 50, at 605 (citations omitted).
134. See Octuplets’ Mom On Welfare, supra note 5 (stating that two of the six embryos
split, and eight babies were born).
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did not violate industry standards. ASRM states the following about
its guidelines:
These guidelines have been developed to assist physicians
with clinical decisions regarding the care of their patients. They
are not intended to be a protocol to be applied in all situations,
and cannot substitute for the individual judgment of the treating
physicians based on their knowledge of their patients and specific
circumstances. The recommendations in these guidelines may not
be the most appropriate approach for all patients. Medical science
and ethics are constantly changing, and clinicians should not rely
solely on these guidelines.135
By its own statement, the ASRM acknowledges that its guide-
lines are flexible. In fact, they are so flexible that a recent study
shows that most clinics do not follow the recommended number of
embryos to implant.136 According to data from the Centers for Disease
Control, over eighty percent of clinics do not follow the guidelines.137
Although the ASRM and SART usually do not sanction or expel
members for failing to follow its guidelines,138 the ASRM expelled
Dr. Kamrava from its membership in September of 2009.139 In early
2010, the California Medical Board filed a disciplinary complaint
against Dr. Kamrava claiming that his conduct, as it pertained to
Octomom, was grossly negligent.140 The industry may be treating
Dr. Kamrava unfairly.
In November of 2009, the ASRM and SART guidelines were
updated in an effort to curtail multi-fetal pregnancies. The current
ASRM and SART guidelines are more structured than prior versions.
For example, in 1994, the guidelines did not mention a specific num-
ber of embryos that should be implanted. Instead, the recommenda-
tion was to transfer a number “so that no quadruplets and no more
than 1% to 2% triplet pregnancies were anticipated.”141 This was
extremely difficult to enforce. In 1998, the ASRM “suggested that
clinics create their own guidelines based on internally generated
135. Practice Committee Guidelines, AM. SOC’Y FOR REPROD. MED., http://www.asrm.org
/Guidelines/ (last visited Nov. 22, 2010).
136. Reynolds, supra note 113.
137. Id.
138. Id.
139. Rita Rubin, ‘Octomom’ Doctor Expelled from Fertility Group, USA TODAY, Oct. 19,
2009, http://www.usatoday.com/news/health/2009-10-18-octomom-doctor-fertility_N.html.
140. Jenny Booth, Nadya Suleman Octuplets Doctor Michael Kamrava Accused of
Negligence, TIMES (London), (Jan. 5, 2010), http://www.timesonline.co.uk/tol/news/world
/us_and _americas/article6976514.ece.
141. Moses, supra note 120, at 592 (citation omitted).
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statistics.”142 The ASRM did make some recommendations in situa-
tions where there was not sufficient clinic data. The recommenda-
tions in 1999 were that physicians should transfer between three
and five good embryos for implantation, “depending on the patient’s
profile, taking into account factors such as age and prior treatment
history.”143
In the late 1990s, the ASRM began to recognize the correlation
between the increased number of embryos transferred and the in-
creased chance of multi-fetal pregnancies. So, in 1999, it shifted its
recommendation to suggest clinics transfer between two and five em-
bryos, while also “allowing adjustments for ‘individual clinic condi-
tions.’ ”144 ASRM removed from the guidelines descriptive words like
“good quality” to describe the embryos, but continued to emphasize
that flexibility was necessary so that there could be adjustments for
individual clinics and patients. Consider the following language:
Strict limitations on the number of embryos transferred, as re-
quired by law in some countries, do not allow treatment plans to
be individualized after careful consideration of each patient’s own
unique circumstances. Accordingly, these guidelines may be modi-
fied according to individual clinical conditions, including patient
age, embryo quality, the opportunity for cryopreservation, and
as clinical experience with newer techniques accumulates.145
The latest revisions to the guidelines state that only one addi-
tional embryo than that recommended in the guidelines should be
transferred, regardless of the patient’s prognosis.146 Additionally,
clinics may be audited if clinics have a multi-fetal pregnancy rate that
is two standard deviations above the mean rate for all reporting
clinics for two consecutive years.147 But, even with the revisions, the
United States is unlike other countries because physicians and clinics
do not face penalties if they violate the embryo transfer limit. ASRM
and SART continue to err on the side of flexibility.148 Even with the
new revisions, the ASRM guidelines are for use when a clinic does not
have internal data to make its own decisions about embryo trans-
fers.149 The guidelines are merely based on data generated by all clinics
142. Id. (citation omitted).
143. Id. (citation omitted).
144. Id. at 592-93.
145. Guidelines on Number of Embryos Transferred, 92 FERTILITY & STERILITY 1518,
1518 (2009).
146. Id.
147. Id.
148. Id.
149. Alan Zarembo & Kimi Yoshino, Octuplets’ Mom Identifies Her Fertility Clinic in
Beverly Hills, L.A. TIMES L.A. NOW BLOG (Feb. 9, 2009), http://latimesblogs.latimes.com
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that provide assisted reproductive technology services.150 A look at
the language from the current guidelines shows that the organiza-
tions did not want to limit a physician’s ability to consider each
patient’s situation on an individual basis.
Those who chastise Dr. Kamrava point to language in the guide-
lines that were in effect before November 2009. Those guidelines
stated that when a patient is under the age of thirty-five, “consider-
ation should be given to transferring only a single embryo.”151 This
language applied, however, only to patients who had a “more favor-
able prognosis.”152 Even though the language suggested that “[a]ll
others in this age group should have no more than” two embryos
transferred,153 the language did excuse unique “individual circum-
stances.”154 The only requirement under the guidelines was that both
the physician and patient should agree on the number of embryos to
be transferred.155 Perhaps Dr. Kamrava, in his professional judgment,
believed Octomom to be an extraordinary circumstance. Octomom
has defended her physician’s decision.156
Before treatment from Dr. Kamrava, Octomom had tried unsuc-
cessfully for seven years to get pregnant; she had used fertility drugs
and artificial insemination.157 She claims to have had a history of
scarred fallopian tubes and miscarriages.158 Dr. Kamrava helped her
achieve pregnancy using in vitro fertilization. He transferred six em-
bryos for implantation in each of her other six pregnancies,159 and the
result in each of those pregnancies was four single-birth pregnancies
and a set of twins. Dr. Kamrava’s pregnancy and live birth rates were
below average, according to the 2006 CDC Report. For women under
35, the average number of embryos transferred in his clinic rate was
3.5 and the live birth rate was 13%. The national average was 2.3
embryos transferred and a 45% live birth rate.160 Additionally,
/lanow/2009/02/octuplets.html (stating that Dr. Michael Kamrava of the “West Coast
Infertility Medical Clinic, now named West Coast IVF Clinic,” transferred far more
embryos than the industry norms and recommendations prescribe).
150. Guidelines on Number of Embryos Transferred, supra note 145, at 1518.
151. Id.
152. Id.
153. Id.
154. Id. at 1519.
155. Id. at 1518.
156. See Zarembo & Yoshino, supra note 149 (noting that Suleman stated that the
procedure was “very appropriate” and that Dr. Kamrava “did nothing different” (internal
quotation marks omitted)).
157. Id.
158. Id.
159. See Octuplets’ Mom On Welfare, supra note 5 (stating that the octuplets were a
surprise; Suleman had expected twins at most).
160. See supra note 122 and accompanying text.
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Octomom’s eggs had been cryopreserved, which often reduces the suc-
cess of a pregnancy.161 Given the past history and clinic data, neither
Dr. Kamrava nor his patient had reason to believe that eight babies
would result from the embryos. In fact, his professional judgment may
have led him to believe that transferring six embryos was necessary
to achieve the successful pregnancy.162
If Octomom had delivered only one or two babies, there would
probably have been no public outcry for legal actions against Dr.
Kamrava. In fact, there are known situations (before Octomom and
Dr. Kamrava) where physicians in clinics with poor conditions trans-
ferred large numbers of embryos to compensate for the poor labora-
tory conditions.163 While Dr. Kamrava has been demonized, other
physicians who have not followed the industry guidelines have been
lauded for creating a miracle birth. One such example is the Kell
family of Atlanta.164 The Kells had tried for several years and spent
several thousand dollars in an attempt to have a child. “Sheri Kell’s
doctor retrieved eight eggs from her ovaries, five of which were
healthy.”165 Three of those eggs developed into embryos after fertil-
ization and “were transferred into [her] body.”166 Sheri delivered a
son nine months later.167
Like Dr. Kamrava, Sheri Kell’s physician adjusted his treatment
to meet Sheri’s individual needs. If he had transferred only one em-
bryo, then she may not have had a successful pregnancy. Sheri had
spent thousands of out-of-pocket dollars on fertility treatments, and
financially, she needed to maximize her chances of having a success-
ful pregnancy.168 Even with the new 2009 ASRM guidelines, Sheri’s
physician might feel justified in transferring two or more embryos.
As ASRM and SART have declined to impose rigid guidelines and
penalties, a federal insurance mandate can strengthen the current
161. See Zarembo & Yoshino, supra note 149 (mentioning that Dr. Kamrava used
“breakthrough technology that revolutionized IVF, reducing risks to both the mother and
the child” (internal quotation marks omitted)).
162. Id.
According to statistics collected by the U.S. Centers for Disease Control, his
clinics performed 20 in vitro procedures in 2006 on women under 35. Of those
procedures, four resulted in pregnancies and only two of those resulted in
birth. One of those women delivered twins. His pregnancy rate and live birth
rate are far below the national average, according to the statistics.
Id.
163. See Moses, supra note 120, at 588 (citation omitted) (stating that these clinics
transfer large numbers of embryos to increase their success rates).
164. Sonji Jacobs, Ethical Boundaries of Baby-Making, ATLANTA J.-CONST., Sept. 17,
2007, at 1A.
165. Id.
166. See id. (stating that three fertilized embryos led to Ms. Kell giving birth to her son).
167. Id.
168. Id.
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ASRM and SART guidelines. Insurers could use the industry infor-
mation from ASRM and SART to set guidelines for reimbursements
and then “mandat[ing] that coverage be provided only for clinics
that report according to federal law or adhere strictly to professional
guidelines.”169 Clinic reimbursements could be linked to a require-
ment that physicians either follow industry guidelines or justify why
they did not follow the guidelines. Mandated insurance coverage
strengthens the existing industry guidelines. This is a real practical
solution to the real problem of in vitro fertilization—multi-fetal preg-
nancies that pose health risks to both mother and child.
If insurance covered in vitro fertilization, perhaps Sheri Kell’s
physician might have encouraged her to transfer one embryo, know-
ing that if she was unsuccessful, she could try again. The Kells might
have agreed with their physician’s recommendation to transfer fewer
embryos because they could afford to try again if the pregnancy was
unsuccessful. Without such coverage, the incentive for both mother
and physician is to transfer multiple viable embryos to the mother
during a single implantation procedure.
The insurance industry could also structure coverage so that
there is a disincentive to participate in procedures that risk the
health of the mother and the children as occurs with multiple em-
bryo transfers:170
In practice, bringing insurance companies or other impersonal
providers into the equation would force a distinction between cases
of infertility, for example, between the twenty-seven-year-old wife
with blocked fallopian tubes, who would most likely qualify for
several cycles of IVF treatment, and the single fifty-three-year
old recovering cocaine addict and ex-felon, who would not.171
Because the low birth weight babies born from multi-fetal preg-
nancies are a public health risk, why not eliminate the risk by requir-
ing insurers to cover the procedure?172 Insurance coverage reduces
the desire to over-implant, which in turn reduces the number of
multi-fetal pregnancies. If insurance coverage were mandated, there
169. Debora Spar & Anna M. Harrington, Building a Better Baby Business, 10 MINN.
J. L. SCI. & TECH. 41, 68 (2009) (citations omitted) (adding that “[c]overage could also be
structured to disallow or to provide disincentives for risky procedures such as multiple
embryo transfer”).
170. Id.
171. Id. (citation omitted).
172. Catherine A. Clements, Note, What About the Children? A Call for Regulation of
Assisted Reproductive Technology, 84 IND. L.J. 331, 343 (2009) (noting that some of the
problems created include significant increases in healthcare costs, and in the use of edu-
cational resources and social services).
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would not be a need to approach embryo transfers as “two for one”
because there would not be large out-of-pocket investments. Both
the patient and her physician would take comfort in knowing that the
patient could afford another cycle.173 This has been true in jurisdic-
tions where insurance coverage is mandated. For example, countries
where insurance covers in vitro fertilization have lower rates of em-
bryo implantation and lower rates of multi-fetal pregnancies than the
United States, where there is no mandatory insurance coverage.174
States with mandated insurance coverage for in vitro fertilization also
have lower transfer rates and fewer multi-fetal pregnancies, even
though there are loopholes in all of the state statutes.175
III. THE SUPREME COURT HAS DECLINED TO IMPOSE A
REQUIREMENT ON INSURERS AND STATE MANDATES ARE VARIED
AND INCOMPLETE
In vitro fertilization coverage is a relatively recent issue. As the
use of in vitro fertilization grew in the 1980s, most insurance plans did
not explicitly address the issue of coverage. Generally, if an insur-
ance contract does not explicitly exclude coverage for a particular
service, then that service is covered under the plan. So, women who
underwent the in vitro fertilization procedure would seek reimburse-
ment from their insurers. Unfortunately, even when insurers claimed
that they covered the procedure, they denied claims. Insurers rea-
soned that the denials were because the procedure was deemed to
be experimental or not medically necessary.176 Fertility advocates,
such as RESOLVE, began to counsel patients.177 They encouraged
individuals to carefully read their insurance policies. Many women
who were denied coverage sought recourse in court; they argued that
without the express exclusion in the policy the services were covered.
As insurers settled claims, they began to categorically deny coverage
for specific fertility treatments such as in vitro fertilization.
173. See DrRChristina, Comment to The Trouble with Twin Births, N.Y. TIMES ROOM
FOR DEBATE BLOG (Oct. 12, 2009, 12:49 PM), http://community.nytimes.com/comments/
roomfordebate.blogs.nytimes.com/2009/10/11/the-trouble-with-twin-births/ (opining that “if
IVF was [sic] less expensive . . . I believe more people wouldn’t give in to the idea of ‘2 for
1’ as readily because they [would] feel comfortable knowing they can afford another cycle”).
174. Norbert Gleicher et al., New Debate: A Formal Comparison of the Practice of
Assisted Reproductive Technologies Between Europe and the USA, 21 HUM. REPROD. 145,
145 (2006).
175. Id.
176. See ARONSON, supra note 42, at 296 (explaining that “most infertility services end
up excluded by inference—insurance companies classify them as ‘experimental,’ ‘not stan-
dard practice,’ or ‘not medically necessary’ ”).
177. Id. at xi.
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One of the first known lawsuits for denial of a medical benefit
was a case against Kaiser Foundation Health Plan of California in
1987.178 After the Kaiser settlement, approximately 10,000 women
qualified for insurance coverage for in vitro fertilization,179 but the
settlement was very specific. It applied only to women “between the
ages of 18 and 45 who were enrolled in Kaiser and suffering from
infertility between July, 1983, and about July, 1985.”180 The settle-
ment did not include coverage for all Kaiser enrollees. For enrollees
requesting coverage for treatment after 1985, Kaiser denied coverage
based on a U.S. Department of Health and Human Services ruling
that stated the procedure was “unusual, infrequently provided and
unnecessary to the health of the patient.”181
In the early 1990s, Jolene Sloter was part of a class action law-
suit against Blue Cross of Western Pennsylvania.182 The insurance
policy did not specifically exclude in vitro fertilization. The company
denied her claim, however, when she sought reimbursement for the
procedure.183 Like Kaiser, Blue Cross agreed to pay a settlement, but
explicitly began to exclude regular coverage of in vitro fertilization
and other advanced reproductive technologies.184
In addition to Blue Cross and Kaiser, in April of 1998, Aetna U.S.
Health Care declared that it would not cover in vitro fertilization and
other advanced reproductive technologies.185 Aetna reasoned that
women chose the plan for its coverage and then left the plan after
benefiting from it.186 Currently, while many private health insurers
cover abortion, contraceptives, and sterilization, they do not cover
in vitro fertilization.187
178. Claire Spiegel & Harry Nelson, Kaiser Agrees to Cover In-Vitro Fertilization, L.A.
TIMES, Sept. 30, 1987, § 1, at 3.
179. See id. (explaining “that Kaiser now concedes that in-vitro fertilization is not
experimental,” and thus, eligible women would be qualified for coverage).
180. Id.
181. Id. (internal quotation marks omitted).
182. See Mackenzie Carpenter, Blue Cross Draws Line on In-Vitro Fertilization
Procedure, PITTSBURGH POST-GAZETTE, June 27, 1993, at A1 (noting that in 1991, Blue
Cross “estimated in a letter to officials at Magee-Womens Hospital that about 95 percent
of all its subscribers were covered for advanced infertility treatments,” including in vitro
fertilization).
183. Id.
184. Id. Jolene Sloter and other women in Western Pennsylvania were reimbursed for
expenses that Blue Cross of Western Pennsylvania initially refused to cover because the
expenses related to infertility. Although Blue Cross did not specifically exclude coverage,
it argued that the procedures were experimental. After the settlement, Blue Cross decided
to state the exclusion in its basic group health insurance policy. Id.
185. Kerr, supra note 50, at 599.
186. Id.
187. D’Andra Millsap, Sex, Lies, and Health Insurance: Employer-Provided Health
Insurance Coverage of Abortion and Infertility Services and the ADA, 22 AM. J.L. & MED.
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The Patient Protection and Affordable Care Act requires that,
by 2014, certain essential benefits must be covered.188 Maternity and
newborn care is one of those essential benefits. In vitro fertilization
coverage should be a part of any maternity benefit.
Congress should address the issue because the Supreme Court
has opted not to impose such a requirement on insurers. Insurers are
not inclined to provide coverage on their own. Insurance coverage will
provide strength to the industry guidelines and eliminate the short
term need for a regulatory entity. Finally, a federal mandate is neces-
sary because state mandates are inadequate: ERISA prevents state
mandates from being comprehensive.
A. The Supreme Court Has Chosen Not to Impose Requirements on
Insurers
The issue of coverage for in vitro fertilization is an issue for
Congress because the Supreme Court has declined to rule on the
issue. Claims have been brought under both the Americans with
Disabilities Act and the Pregnancy Discrimination Act; circuits are
split. The issue should not be left to patchwork interpretation by
conflicting circuits. Rather, Congress should take action.
1. Pregnancy Discrimination Act
Congress passed the Pregnancy Discrimination Act (PDA) in
1978.189 It amended Title VII of the Civil Rights Act of 1964 to
protect pregnant women from workplace discrimination.190 The Act
applies to employers with fifteen or more employees and prohibits
discrimination in the workplace on the basis of “pregnancy, child-
birth, or related medical conditions.”191 The Act also provides that
“[a]ny health insurance provided by an employer must cover expenses
for pregnancy-related conditions on the same basis as costs for other
51, 53-54, 57 (1996) (citing ALAN GUTTMACHER INSTITUTE, UNEVEN & UNEQUAL: INSURANCE
COVERAGE AND REPRODUCTIVE HEALTH SERVICES 11, 18 (1994)).
188. Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, § 1302, 124
Stat. 119 (2010) (to be codified at 29 U.S.C. § 207).
189. Pregnancy Discrimination Act, Pub. L. No. 95-555, 92 Stat. 2076 (1978) (codified
at 42 U.S.C. § 2000e(k) (2000)).
190. Katherine E. Abel, Note, The Pregnancy Discrimination Act and Insurance
Coverage for Infertility Treatment: An Inconceivable Union, 37 CONN. L. REV. 819, 819
(2005) (citing 42 U.S.C. § 2000e(k) (2000)).
191. 42 U.S.C. § 2000e(k) (2000). This act is meant “to prohibit sex discrimination on the
basis of pregnancy,” and begins by explaining that “the terms ‘because of sex’ or ‘on the
basis of sex’ include, but are not limited to, because of or on the basis of pregnancy, child-
birth, or related medical conditions.” Id.
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medical conditions.”192 While abortion expenses were expressly ex-
cluded from the mandate, the Act is silent as to whether infertility is
a protected medical condition related to pregnancy.193
The Act appears to be clear on its face, but in vitro fertilization
was not a common procedure when the Act was passed. Thus, the
phrase “related medical condition” is ambiguous as it applies to in
vitro fertilization. Although the Supreme Court held in International
Union v. Johnson Controls, Inc. that “[w]omen who are either preg-
nant or potentially pregnant must be treated like others ‘similar in
their ability . . . to work,’ ”194 the Court stopped short of ruling that
the PDA requires insurance coverage of in vitro fertilization. Nor did
the Court rule that denial of such coverage is discriminatory.
Most recently, the Seventh Circuit held that Title VII provided
a viable claim to a woman who was allegedly terminated from her job
for undergoing in vitro fertilization.195
The Court reasoned that, although infertility afflicts both sexes
equally, the employer conduct under dispute nevertheless was
not gender neutral because only women take time off to undergo
IVF. Consequently, Nalco’s alleged policy of terminating employees
for undergoing IVF treatments was sexually discriminatory be-
cause only females would ever be fired on such grounds.196
The Seventh Circuit accurately placed in vitro fertilization within
the boundaries of the Pregnancy Discrimination Act. This would set
the stage to prevent insurers from denying coverage for the procedure.
The Second and Eighth Circuits, however, have reached a different
result. In both Saks v. Franklin Covey Co.197 and Krauel v. Iowa
Methodist Medical Center,198 summary judgment was granted to the
employer, showing that such circuits held that infertility does not
constitute a “related medical condition.” Those courts reasoned that
if men and women receive equal treatment under an insurance plan,
192. Facts about Pregnancy Discrimination, EQUAL EMP’T OPPORTUNITY COMM’N,
http:// www.eeoc.gov/facts/fs-preg.html (last visited Nov. 22, 2010).
193. Pregnancy Discrimination Act, Pub. L. No. 95-555, 92 Stat. 2076 (1978) (codified
at 42 U.S.C. § 2000e(k) (2000)).
194. Int’l Union v. Johnson Controls, Inc., 499 U.S. 187, 204 (1991) (quoting 42 U.S.C.
§ 2000e(k) (2000)).
195. Hall v. Nalco Co., 534 F.3d 644, 645 (7th Cir. 2008).
196. Employment Law—Title VII—Seventh Circuit Allows Employee Terminated for
Undergoing In Vitro Fertilization to Bring Sex Discrimination Claim—Hall v. Nalco Co.,
534 F.3d 644 (7th Cir. 2008), 122 HARV. L. REV. 1533, 1535 (2009) (citing Hall, 534 F.3d
at 648-49).
197. See Saks v. Franklin Covey Co., 117 F. Supp. 2d 318, 330 (S.D.N.Y. 2000) (granting
summary judgment to the employer).
198. See Krauel v. Iowa Methodist Med. Ctr., 95 F.3d 674, 681 (8th Cir. 1996) (granting
summary judgment to the employer).
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then a plan that does not provide coverage for infertility procedures
is not discriminatory because the limitations affect both men and
women, and, therefore, are not gender specific.199
2. Americans With Disabilities Act
The Americans With Disabilities Act ADA “is an anti-discrimi-
nation statute passed with the intention of allowing qualified indi-
viduals with disabilities [to] enjoy the same employment opportunities
as people without disabilities.” 200 Scholars have also opined as to
whether the ADA extends to treatment for infertility. “When the ADA
was passed, many infertile advocates believed that if reproduction
was recognized as a major life activity under the ADA, then the ADA
would effectively force employers to accommodate employees who wish
to undergo infertility treatments and compel health insurers to in-
clude infertility insurance in their plans.” 201 This has not happened.
The Supreme Court held in Bragdon v. Abbott that reproduction
is a major life activity.202 Abbott sued under the ADA and claimed that
Bragdon, a dentist, had discriminated against her when he refused to
treat her because she was living with HIV.203 In order to qualify for
protection from discrimination under the ADA, one must have “a
physical or mental impairment that substantially limits one or more
of the major life activities of such individual.” 204 “Abbott argued that
her HIV status substantially limited the major life activity of repro-
duction,” and the Supreme Court agreed.205 Because her “HIV infection
substantially limited her ability to reproduce . . . she was afforded
protection from discrimination under the ADA.” 206 Because the Court
ruled that reproduction was a major life activity, scholars began to
discuss whether there is a basis to claim discrimination under the
ADA if an employer discriminates against an infertile employee.
Unfortunately, Bragdon has not had the effect that many hoped
for. In Saks, the district court held that failure to provide infertility
insurance was not a violation of the ADA because the plan “does not
199. Saks v. Franklin Covey Co., 316 F.3d 337, 348 (2d Cir. 2003) (citing Johnson
Controls, 499 U.S. at 198) (stating that “the exclusion of surgical impregnation techniques
limits the coverage available to infertile men and infertile women and, thus does not
violate Title VII”).
200. James B. Roche, After Bragdon v. Abbott: Why Legislation is Still Needed to
Mandate Infertility Insurance, 11 B.U. PUB. INT. L.J. 215, 220 (2002) (citation omitted).
201. Id. (citation omitted).
202. Bragdon v. Abbott, 524 U.S. 624, 638 (1998).
203. Id. at 628-29.
204. Americans with Disabilities Act of 1990, 42 U.S.C. § 12102(2)(A) (2008).
205. Roche, supra note 200, at 220.
206. Id. (citations omitted).
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offer infertile people less pregnancy and fertility-related coverage
than it offers to fertile people. Therefore, as a matter of law, the Plan
does not violate the ADA.” 207
The ADA treats health insurance terms and conditions more
deferentially than actions such as hiring and firing of employees. “The
statute specifically provides a safe harbor for certain insurance plans
that are based on ‘underwriting risks, classifying risks, or adminis-
trating risks’ that are based on or not inconsistent with state law.” 208
Furthermore, “health insurance plans do not run afoul of the ADA
when they discriminate among types of disabilities so long as all the
employees, regardless of disability status, have equal access to the
available range of benefits.” 209
B. State Mandates Are Inconsistent and Can Never Be
Comprehensive
Critics of a federal mandate for in vitro fertilization often claim
that insurance is a state issue. The McCarran-Ferguson Act allows
states to regulate “the business of insurance” without federal gov-
ernment interference.210 The Act does not prevent Congress from
passing laws to regulate the “business of insurance.” 211 We have just
witnessed the passage of The Patient Protection and Affordable Care
Act and the Health Care and Education Reconciliation Act of 2010.212
These new laws have expanded health care access and coverage. In
the same way that Congress passed legislation in the 1990s to require
insurers to cover a certain length of hospital stay after childbirth,213
Congress should now pass legislation to mandate that insurers cover
in vitro fertilization.
A typical search for states with statutes that address insurance
coverage of fertility treatments usually lists fifteen states.214 There
207. Saks v. Franklin Convey Co., 117 F. Supp. 2d 318, 326 (S.D.N.Y. 2000).
208. Colleen E. Medill et al., Coverage of Reproductive Technologies Under Employer-
Sponsored Health Care Plans: Proceedings from the 2004 Annual Meeting, Association of
American Law Schools, Sections on Employee Benefits and Employment Discrimination,
8 EMP. RTS. & EMP. POL’Y J. 523, 531 (2004) (quotation omitted).
209. Id.
210. McCarran-Ferguson Act of 1945, 15 U.S.C. §§ 1011-1015 (2000).
211. Id.
212. Patient Protection and Affordable Care Act, Pub. L. No. 111-148, 124 Stat. 119
(2010); The Health Care and Education Reconciliation Act of 2010, Pub. L. No. 111-152,
124 Stat. 1029 (2010).
213. Nduka U. Udom & Charles L. Betley, Effects of Maternity-Stay Legislation on
‘Drive-Through Deliveries,’ 17 HEALTH AFF. 208, 208 (1998).
214. Insurance Coverage in Your State, RESOLVE: THE NAT’L INFERTILITY ASS’N,
http:// www.resolve.org/family-building-options/insurance_coverage/state-coverage.html
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is no uniformity among these fifteen states. In fact, several of these
jurisdictions receive kudos for what amounts to inadequate coverage.
In addition, even the most comprehensive state plan cannot go beyond
the Employee Retirement Income Security Act (ERISA) exemption
for self-insured plans. Such a provision leaves many individuals con-
fused as to why they live in a jurisdiction that mandates insurance
coverage for in vitro fertilization but their insurance plan does not
have to adhere to the mandate.
1. Massachusetts Is Good, But Not Good Enough
Massachusetts offers the most comprehensive state insurance
mandate.215 The state mandate applies to commercial insurers, non-
profit insurers such as Blue Cross/Blue Shield, and HMOs.216 Mas-
sachusetts requires any insurer that provides pregnancy-related
benefits to provide coverage for all non-experimental infertility diag-
nosis and treatment.217 In addition to in vitro fertilization, the treat-
ment includes artificial insemination, gamete intra fallopian transfers,
sperm, egg or inseminated egg procuring and processing, intracy-
toplasmic sperm injection, and zygote intra fallopian transfers.218
Even if every state followed that model and enacted mandatory in-
surance coverage, there would not be comprehensive coverage. ERISA
would exempt employers who self-fund their insurance. As approxi-
mately fifty-five percent of individuals with health insurance are
covered under self-insured plans,219 there is a serious need for a
federal mandate.
Massachusetts is perhaps where critics should look when they
suggest that premiums would increase with the mandate and ulti-
mately leave more individuals uninsured. Massachusetts has im-
posed no limit on treatment cycles and there are no lifetime caps for
benefits.220 Data suggests that a larger percentage of the population
[hereinafter Insurance Coverage in Your State] (last visited Nov. 22, 2010). These states
include Arkansas, California, Connecticut, Hawaii, Illinois, Louisiana, Maryland,
Massachusetts, Montana, New Jersey, New York, Ohio, Rhode Island, Texas, and West
Virginia. Id.
215. 211 MASS. CODE REGS. 37.00 (LexisNexis 2010).
216. Id. at 37.03 (referring to MASS. ANN. LAWS ch. 175, § 1 (LexisNexis 2010); MASS.
ANN. LAWS ch. 176A, § 1 (LexisNexis 2010); MASS. ANN. LAWS ch. 176B, § 1 (LexisNexis
2010); MASS. ANN. LAWS ch. 176G, § 1 (LexisNexis 2010)).
217. Id. at 37.05.
218. Id.
219. Karrie Andes, Self-Insuring is a Way for Employers to Get ‘a Whole Lotta Cannoli,’
23 EMP. BENEFIT NEWS, Mar. 2009, at 9.
220. See Carpenter, supra note 182, at A1 (noting that Massachusetts “mandat[es] that
all insurers pay for an unlimited number of cycles of in-vitro fertilization as part of a basic
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utilizes the services than when the service was not covered by insur-
ance. Even so, the data from Massachusetts shows that this mandate
on fertility treatments and drugs has only minimally affected insur-
ance premiums. “[T]he cost of insurance premiums has risen only be-
tween 0.2 percent and 0.5 percent annually, or about $1 a month
extra for an average policy, because of the coverage of in-vitro fertil-
ization.” 221 As costs are shared among the larger population, no one
is unduly burdened.
Massachusetts defines infertility as when an otherwise healthy
individual is unable to conceive or produce conception within a year.222
Although Massachusetts law states that insurers may set reasonable
eligibility requirements, such requirements may not be arbitrary.223
As such, this protects the patient when the insurer attempts to arbi-
trarily deny a claim. Insurers may look to the ASRM as a guide for
implementing standards.224 Furthermore, an insurer may not impose
additional deductibles, co-payments, waiting periods, benefit maxi-
mums, or other limitations on coverage for fertility benefits that are
not imposed on other services.225 The mandate applies to the policy
holder, as well as to the spouse or other dependents.226
There are higher utilization rates in Massachusetts and other
states with insurance mandates. Data from 2002 showed states with
comprehensive coverage had a three-fold utilization rate than those
states where there was no mandated coverage.227 This information
suggests that women and couples who are interested in infertility
treatments do not pursue the treatment because of the costs associ-
ated with the procedure.228 Given that the demand will increase, any
federal legislation should probably have some limits to curtail costs.
2. State Mandates Can Never Be Comprehensive Because of
ERISA Preemption
Although Congress passed the Employee Retirement Income
Security Act of 1974 (ERISA) to address pension programs and ensure
that such programs are managed and funded properly,229 the Act goes
insurance policy”).
221. Id.
222. 211 MASS. CODE REGS. 37.03 (LexisNexis 2010).
223. Id. at 37.09.
224. Id.
225. Id. at 37.08.
226. Id. at 37.04.
227. Tarun Jain & Mark D. Hornstein, To Pay or Not To Pay, 80 FERTILITY &
STERILITY 27, 27 (2003).
228. Id.
229. Michael D. Miller, ERISA: The Unbridged Chasm of Health Reform—Challenges
for Massachusetts and Federal Action, HEALTH POLICY AND COMMUNICATIONS BLOG
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beyond pension programs and governs all employee welfare benefit
plans, including disability and health benefit plans. As self-insured
health plans are a type of employee welfare plan, they are exempt
from state mandates. ERISA contains a broad preemption clause that
expressly preempts state laws that conflict with the federal regulation
of employee welfare benefit plans.230 Although there is a savings clause
within ERISA that exempts state laws regulating insurance, ERISA
deems that an employee welfare benefit plan is not an insurance
plan.231 Ultimately, ERISA leaves employees confused as to why their
insurer is not required to cover a service in spite of a state mandate.
Most individuals obtain their insurance through a group plan
offered by their employer.232 This will most likely remain true even
after the options provided by the Patient Protection and Affordable
Care Act are in effect. While there is no federal or state requirement
that employers offer insurance coverage, once an employer chooses
to offer insurance, federal and state requirements exist. Employers
that do offer insurance coverage have a variety of options. They may
purchase the insurance directly from the insurer or insurance com-
pany. If they choose this route, they may choose from commercial com-
panies such as Aetna or Cigna,233 or a non-profit company such as the
various Blue Cross/Blue Shield plans.234 Employers may also self-
insure and allow an insurance company or other third party admin-
ister the plan.235 Self-insured plans are those where an employer has
chosen to pool the risks of its employees and benefit from a healthy
work force.236
The employer’s goal is to provide quality care at low costs. So,
no matter which option an employer chooses to offer its employees,
plans under the option may include one or all of the following: Health
Maintenance Organizations (HMOs), Point of Service (POS), or Pre-
ferred Provider Organizations (PPOs).237 Generally speaking, an HMO
means tighter provider choices from a list of in-network providers,
whereas PPOs allow for greater individual choice.238 The POS is a
(Sept. 9, 2008), http://www.healthpolcom.com/blog/2008/09/09/erisa-the-unabridged-chasm
-of-health-reform-%E2%80%93-Challenges-for-Massachusetts-and-federal-action/.
230. Id.
231. Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1144(b)(2)(B) (2010).
232. Health Insurance 101, RESOLVE: THE NAT’L INFERTILITY ASS’N, http://www.resolve
.org /family-building-options/insurance_coverage/health-insurance-101.html [hereinafter
Health Insurance 101] (last visited Nov. 22, 2010).
233. Id.
234. Id.
235. Medill et al., supra note 208, at 541.
236. Id.
237. Health Insurance 101, supra note 232.
238. Id.
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middle ground that offers an in-network option and a higher payment
scale if an individual chooses to use an out-of-network provider.239
Employees are often unaware of the type of plan, purchased or
self-funded, until a determination must be made with respect to cov-
ered services. Many erroneously assume that if they live in a state
with mandated coverage for in vitro fertilization, their insurers must
provide coverage for the procedure. Because ERISA does not require
self-funded insurance plans to adhere to state insurance mandates,
when an employer chooses to self-fund insurance benefits, its em-
ployees are not protected by any state insurance law mandates.240
“As of 2003, the majority of covered workers are in a plan that is
completely or partially self-insured.” 241 Thus, state mandates will
never be comprehensive.
The rationale behind the exemption of self-funded plans was that
large companies do businesses in several states. It would be more
than cumbersome to require such employers to adhere to state laws
in several states. Unfortunately, it is the employee who ends up
losing out, and she or he has no real recourse. Even in a state like
Massachusetts where there is comprehensive coverage for in vitro
fertilization, individuals in the state may find themselves not cov-
ered when it comes to in vitro fertilization. Thus, a federal mandate
is necessary. Such federal legislation would amend ERISA so that
such self-funded plans are not excluded from any insurance mandate
to cover in vitro fertilization.
3. State Coverage Is Too Varied and Too Incomplete
The states with statutory mandates for in vitro fertilization
coverage vary greatly with respect to requirements for coverage. Such
variances include age restrictions for patients who seek the service,
number of employees necessary for employers to be covered under the
legislation, residence of the insured, number of in vitro cycles covered,
number of embryos transferred per cycle or lifetime, whether donor
eggs may be used, and lifetime monetary caps.242 Some states limit
insurance coverage to women under a certain age. Others require
that the procedure be limited to situations where a woman’s eggs
are fertilized with her husband’s sperm.243 Also, when an individual
239. Id.
240. Id.
241. THE KAISER FAMILY FOUND. & HEALTH RESEARCH & EDUC. TRUST, EMPLOYER
HEALTH BENEFITS: 2003 ANNUAL SURVEY 124 (2003), available at http://www.kff.org/
insurance/ehbs2003-1-set.cfm (follow “Download PDF: Entire Document” hyperlink).
242. Insurance Coverage in Your State, supra note 214.
243. See id. Maryland, Arkansas, Texas and Hawaii all require use of the husband’s
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works in one state but the insurance plan is from another state, she
is not necessarily covered by the state plan mandating insurance com-
panies to cover the procedure.244 Several jurisdictions reference the
American Society of Reproductive Medicine (ASRM) or the American
College of Obstetricians and Gynecologists (ACOG), requiring that
any procedures must be performed in clinics that conform to industry
standards.245 Some state mandates apply to HMOs, while others spe-
cifically exclude HMOs. Some of the legislation is written in a way
that allows for broad interpretation, while other legislation is straight-
forward. Some states define infertility and others do not. All of the
variables leave the patient confused and often uncovered in situations
where she thought coverage existed. “Recent statistics show that
insurance providers cover [in vitro] costs about thirty to forty percent
of the time in states that mandate at least some type of coverage. For
the thirty to forty percent who are covered, insurance pays an average
of fifty percent of the total cost.” 246
As previously stated, Massachusetts offers the most compre-
hensive legislative mandate.247 Maryland, Connecticut, Illinois, New
Jersey, and Rhode Island offer reasonably comprehensive mandates.248
These state laws may also be used as models to draft federal legisla-
tion, especially when there is a need to balance the risks and costs
sperm. Such restrictions may be de facto discrimination against single women and homo-
sexual couples. Id.
244. See MD. CODE ANN., INS. § 15-810 (West 2010) (stating that the section applies to
health insurance policies issued or delivered in Maryland); MD. CODE ANN., HEALTH- GEN.
§ 19-701 (West 2010) (characterizing the health maintenance organizations affected by
the statute as those operating in Maryland).
245. See Insurance Coverage in Your State, supra note 214. States that require that fer-
tilization procedures follow the ASRM or ACOG industry standards include: Arkansas,
Hawaii, Illinois, and Texas. Connecticut requires fertilization procedures to conform to
both the ASRM standards and the Society of Reproductive Endocrinology and Infertility
guidelines. Id.
246. Thomas D. Flanigan, Note, Assisted Reproductive Technologies and Insurance
Under the Americans with Disabilities Act of 1990, 38 BRANDEIS L.J. 777, 781 (2000)
(citing Peter J. Neumann, Should Health Insurance Cover IVF? Issues and Opinions, 22
J. HEALTH POL. POL’Y & L. 1215, 1217-18 (1997)).
247. Insurance Coverage in Your State, supra note 214; see also MASS. GEN. LAWS ANN.
ch. 175, § 47H (West 2010) (stating that insurance policies that provide pregnancy-related
benefits must also provide coverage for medically necessary expenses for the diagnosis and
treatment of infertility); MASS. GEN. LAWS ANN. ch. 176A, § 8K (West 2010) (mandating
that under health insurance contracts, except those providing supplemental coverage to
Medicare or other governmental programs, infertility benefits be provided when coverage
is offered for other pregnancy-related procedures); MASS. GEN. LAWS ANN. ch. 176B, § 4J
(West 2010) (requiring that subscription certificates under individual or group medical
service agreements provide infertility benefits “to the same extent that benefits are pro-
vided for other pregnancy-related procedures”); MASS. GEN. LAWS ANN. ch. 176G, § 4 (West
2010) (listing treatment of infertility as a category of required coverage in a health main-
tenance contract); 211 MASS. CODE REGS. 37.00 (West 2010) (stating that insurers must
provide benefits to insured spouses or dependants for required infertility procedures).
248. Insurance Coverage in Your State, supra note 214.
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associated with in vitro fertilization. Several states give an illusion
of coverage, when in practice, there are no real benefits to patients/
consumers. Arkansas, Hawaii, Montana, New York, Ohio, West
Virginia, and Louisiana have legislation that is less than compre-
hensive when it comes to coverage for in vitro fertilization.249 New
York and California explicitly exclude in vitro fertilization from their
mandates for infertility coverage.250 California and Texas only man-
date that insurers that cover pregnancy services offer coverage for
infertility treatment.251 Even though insurers must let employers
know that this coverage, is available, insurers are not required to
provide the coverage and employers are not required to include it in
their health plans.252 Thirty-five states have not addressed the issue
at all.
IV. CONGRESS SHOULD PASS THE FAMILY BUILDING ACT—WITH
REVISIONS
A. The Family Building Act
In January of 2009, Congressman Anthony Weiner introduced
the Family Building Act (H.R. 697).253 To date the legislation has only
twenty co-sponsors.254 Although it has been referred to the committees
with jurisdiction over the issue, no action has been taken.255 A compan-
ion bill (S. 1258) was introduced in the Senate by Kirsten Gillibrand.256
There are no co-sponsors for the Senate bill.257
The legislation is a good start and a good way to bring the issue
of insurance coverage for in vitro fertilization into the public domain.
Federal legislation does not need to mandate that insurers cover
everything related to in vitro fertilization, and the Family Building
Act does have limitations.258 The legislation appropriately weighs the
costs and benefits of the procedure against any risks associated with
249. Id.
250. N.Y. INS. LAW § 3221(k)(6)(B)(v)(I) (Consol. 2010); CAL. HEALTH & SAFETY
§ 1374.55(a) (West 2010).
251. CAL. INS. CODE § 10119.6(a) (West 2005); TEX. INS. CODE ANN. §§ 1366.001-1366.059
(West 2009).
252. Insurance Coverage in Your State, supra note 214.
253. Zhang, supra note 13.
254. THOMAS (Library of Congress), H.R. 697 Cosponsors, http://thomas.loc.gov/cgi-bin/
bdquery/z?d111:HR00697:@@@P (last visited Nov. 22, 2010).
255. Id.
256. THOMAS (Library of Congress), S. 1258 Bill Summary & Status, http://thomas
.loc.gov/cgi-bin/bdquery/z?d111:SN01258 (last visited Nov. 22, 2010).
257. Id.
258. The Family Building Act of 2009 covers assisted reproductive technologies.
Congressman Weiner introduced the legislation in the 109th and 110th Congresses. H.R.
697, 111th Cong. (1st Sess. 2009); S. 1258, 111th Cong. (1st Sess. 2009).
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the procedure. The “right to procreate does not necessarily translate
into a right to have the cost of reproductive technologies covered by
the state. For example, in Maher v. Roe, the Supreme Court held that
the right to an abortion did not include the right to state funding for
it.” 259 The same logic can apply to the “right to insurance coverage.”
Even if Congress mandates insurers to cover in vitro fertilization, it
does not have to be unlimited and everlasting.
B. Issues That Congress Should Discuss to Strengthen the
Legislation
The Family Building Act could have more depth. A comparison
to some of the state mandates suggests that there are provisions that
could make the document stronger. Ultimately, Congress would need
to garner support from physicians and insurers in order for the legis-
lation to pass. This task is not necessarily insurmountable.
RESOLVE currently has a list of questions that patients should
have answered by their current insurers as they determine whether
treatment for infertility is covered under their insurance plan.260 Many
of these questions should be answered as federal legislation is drafted.
Such questions include how to define infertility, whether the coverage
is limited only to infertile couples, age limits for any coverage, whether
less costly methods must first be exhausted before in vitro fertilization
is covered, whether coverage benefits apply only to married couples,
whether the woman’s eggs must be fertilized with her spouse’s sperm,
and whether insurance coverage should apply to donors.261 Other
questions that federal legislation should address include the issue
of pre-existing conditions, number of embryo transfers, coverage for
cryopreservation, and maximum benefits of coverage.
1. Offer Versus Cover
The Family Building Act of 2009 is a mandate for insurers to
provide coverage for in vitro fertilization.262 One of the first issues
to address is whether a federal mandate should only require that in-
259. Spar & Harrington, supra note 169, at 51 (citing Maher v. Roe, 432 U.S. 464, 474
(1977)). “The Constitution imposes no obligation on the States to pay the pregnancy-related
medical expenses of indigent women, or indeed to pay any of the medical expenses of
indigents . . . .” Id. (quoting Maher, 432 U.S. at 474).
260. Diane Clapp, Questions to Ask Series: When Choosing an Insurance Policy,
RESOLVE: THE NAT’L INFERTILITY ASS’N, http://www.resolve.org/family-building-options/
insurance_coverage/coverage-at-work.html (follow “Questions to Ask Regarding Health
Insurance Policies” hyperlink under “For Employees”) (last visited Nov. 22, 2010).
261. Id.
262. Zhang, supra note 13.
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surers offer an option. Those in favor of a mandate to offer argue that
a mandate for coverage requires individuals to pay for a service that
they will not use. This is true; however, each of us already pays for
services and treatments that do not apply to us. Although California
and Texas only require insurers to offer a plan, this is not the ap-
proach that federal legislation should take. A mandate to provide
coverage means that there is a larger pool over which to spread costs.
Thus, the overall cost to everyone is smaller than with only a man-
date to offer coverage. Any federal mandate should indeed require
all insurers who provide maternity benefits to provide coverage for
in vitro fertilization. “[T]he purpose of health insurance is to pool
risks in order to provide affordable health care for all members.” 263
2. Group Plans, HMOs, Individual Plans, or What?
What types of plans should be covered under a federal mandate?
The Family Building Act of 2009 appropriately mandates coverage
for group health plans, health insurance issuers offering group health
insurance, and insurance offered through the individual markets and
through the Federal Employees Health Benefit Plans, if such plan
provides obstetrical services. The Act applies to large or small group
markets and, presumably, does not limit the mandate to employers
who have only a certain number of employees. In contrast, the
Pregnancy Discrimination Act applies to employers with fifteen or
more employees, and it includes federal, state, and local governments,
employment agencies, and labor organizations.264
Some state mandates apply only to group health insurers, and
others apply only to HMOs. For example, the West Virginia and Ohio
mandates apply only to HMOs.265 California limits its mandate to
group health insurers.266 Some states require a minimum number of
employees before the mandate applies to group health insurers. For
example, although the Maryland legislature enacted legislation that
mandated private insurance companies to cover infertility services,
including in vitro fertilization,267 the law applies only to policies issued
in Maryland, and only to employers with more than fifty employees.268
If a Maryland resident is insured under a policy issued in another
263. Jessica L. Hawkins, Note, Separating Fact from Fiction: Mandated Insurance
Coverage of Infertility Treatments, 23 WASH. U. J.L. & POL’Y 203, 224 (2007) (citing John
V. Jacobi, The Ends of Health Insurance, 30 U.C. DAVIS L. REV. 311, 312 (1997)).
264. 42 U.S.C. § 2000e(b) (2006).
265. Insurance Coverage in Your State, supra note 214.
266. Id.
267. Jain & Hornstein, supra note 227, at 27.
268. Insurance Coverage in Your State, supra note 214.
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state, the Maryland statute is not applicable to such Maryland resi-
dent.269 If her employer has less than fifty employees, such employer
is also not covered by the state mandate.270 New Jersey similarly
limits its mandate to provide coverage for in vitro fertilization to em-
ployers with fifty or more employees.271 Illinois law applies to policies
that cover more than twenty-five people.272
Several states specifically provide a religious exclusion for em-
ployers who have a bona fide religious reason for not providing cov-
erage for in vitro fertilization. Those states are Connecticut, Illinois,
Maryland, New Jersey, and Texas.273 While the Family Building Act
does not mention such an exclusion, it probably should. In the alter-
native, a provision for a religious exclusion should be implemented
through any regulations.
3. Deductibles
Given that employers are not required to offer insurance cover-
age, a federal mandate should not be so onerous as to cause the
employer to eliminate health insurance benefits for its employees.
The Family Building Act is silent as to any caps on lifetime benefits.
It merely states that deductibles, coinsurance, and other cost-sharing
or limitations should not exceed those applied to similar services.
Comparatively, Maryland and Arkansas have lifetime maximum
benefits. In Maryland, that amount is $100,000, far more reasonable
than the $15,000 that the Arkansas law permits insurers to impose.274
This issue should be further addressed during committee hearings.
4. Embryos
Should a federal mandate restrict the number of embryos trans-
ferred for implantation? If so, what is the appropriate number of
embryos to be transferred? How much deference should be given to
a physician’s professional judgment? Should there be a penalty on
physicians who transfer more than a certain number of embryos?
Would Octomom’s physician, who transferred six embryos for implan-
tation, receive reimbursement for his services?
Multi-fetal pregnancies are significantly more frequent in the
United States than in Europe.275 The main reason is that the number
269. MD. CODE ANN., INS. § 15-810(a)(1) (West 2000).
270. Insurance Coverage in Your State, supra note 214.
271. Id.
272. Id.
273. Id.
274. Id.
275. Gleicher et al., supra note 174, at 1949.
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of embryos transferred is significantly different. A physician in the
United States is far more likely to transfer multiple embryos than
a physician in most European countries. A comparison of situations
where a physician transferred four or more embryos shows this group
represented 31.9% of women in the United States but only 5.5% of
European patients.276 As the women were similar in age, the distin-
guishing factor appears to be insurance coverage for the procedure.
Coverage deterred the desire of women to request multiple transfers
and for physicians to perform multiple transfers.
“Germany, Sweden, Denmark, and Switzerland limit implanta-
tions to three pre-embryos, at most, per cycle,” and the United King-
dom has a limit of two implantations.277 In Germany, it is a felony to
breach the number of embryos to transfer.278 But such a limit may not
be necessary in the United States. “In most states of Australia and in
New Zealand, there is no mandatory limit on the number of embryos
that may be transferred. Still, the number of embryos transferred per
cycle is on average significantly less than in the United States . . . .” 279
These results tend to suggest that coverage alone is enough of a
deterrent for physicians and patients.
The Family Building Act does not, and should not, restrict cov-
erage to a single embryo transfer.280 In fact, the bill does not state
how many embryos should be transferred for implantation. It only
requires that the medical facility conform to ASRM standards or any
standards set by an appropriate federal agency.281 This is a sound ap-
proach. A single embryo transfer sounds too much like government en-
tering the womb, which is not something the American culture would
readily agree to.282 Rather, it is reasonable to rely on the expertise of
276. Id. at 1947.
277. Rosato, supra note 97, at 86 (citation omitted).
278. See Gesetz zum Schutz von Embryonen [ESchG] [Embryo Protection Act],
Dec. 13, 1990, BGBL. I at 2746, § 1, no. 3 (Ger.) (stating that violations of the Act, includ-
ing “attempts, within one treatment cycle, to transfer more than three embryos into an
woman[,]” may result in imprisonment not exceeding three years); see also THE GERMAN
PENAL CODE 6 (Stephen Thaman trans. 2002) (defining felonies under German law as
“unlawful acts punishable by imprisonment one year or more”); Germany’s Embryo
Protection Law is ‘Killing Embryos Rather Than Protecting Them,’ HEALTH & MED. WEEK
(July 16, 2007), available at http://www.newsrx.com/newsletters/Health-and-Medicine
-Week/2007-07-16/2007162007515W.html (“The German embryo protection law, passed in
1991, stipulates that no more than three embryos can be created per cycle of IVF and all
three, regardless of their quality, must be transferred to the patient’s womb at one time,
and cannot be frozen or discarded.”).
279. Moses, supra note 120, at 596.
280. See H.R. 697, 111th Cong. (1st Sess. 2009) (detailing the lifetime cap of six
retrievals); S. 1258, 111th Congress (1st Sess. 2009) (detailing the lifetime cap of six
retrievals).
281. Id.
282. Davi Stamford, Comment to The Trouble with Twin Births, N.Y. TIMES ROOM FOR
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ASRM and SART to provide guidance as to the range of acceptable
number of embryos to transfer.283 Clinics with lower success rates
should have to explain the conditions in which they perform the
procedure and explain why their rates are lower than the industry
average. Clinics with pregnancy rates too far removed from the in-
dustry average will not be reimbursed if they attempt to overcompen-
sate for their deficiencies with larger embryo transfers. This should
prevent another Octomom. A requirement that clinics adhere to in-
dustry guidelines in order to receive reimbursement from insurers
does not limit rights of a physician or patient, but it gives an incentive
for each to follow industry standards and explains why they do not
follow them.
The Fertility Clinic Success Rate and Certification Act could also
be amended such that twins and triplets do not count as “success”
when calculating successful pregnancies. This change, as well as cov-
erage for the procedure, may deter transferring larger numbers of
poorer quality embryos.
5. Cycle Limitations
How many cycles of in vitro fertilization should an insurer be
required to cover? There are at least two scenarios for an insurer to
consider: (i) the case where a woman tries to sustain a pregnancy on
multiple occasions yet she is unsuccessful, and (ii) the case when a
woman who successfully produced a child desires a second or third
child. At some point, it is not economically feasible for an insurer to
continue to provide coverage when a woman is not successful. Equally
important is whether an insurer should fund unlimited pregnancies.
After all, each of Octomom’s pregnancies was a result of in vitro
fertilization.
The Family Building Act caps the number of egg retrievals at
six.284 It is similar to the language in the Illinois statute, where “[e]ach
patient is covered for up to 4 egg retrievals. However, if a live birth
occurs two additional egg retrievals will be covered, with a lifetime
maximum of six retrievals covered.” 285 In contrast, Maryland allows
insurance companies to limit their coverage to three attempts per live
birth.286 Hawaii is extremely limited in that it only covers one cycle
DEBATE BLOG (Oct. 12, 2009, 12:09 PM), http://roomfordebate.blogs.nytimes
.com/2009/10/11/the-trouble-with-twin-births/ (“Keep the government out of the womb.”).
283. Stillman, supra note 17.
284. H.R. 697, 111th Cong. (1st Sess. 2009); S. 1258, 111th Cong. (1st Sess. 2009).
285. Insurance Coverage in Your State, supra note 214. The statute applies to HMOs and
group health insurers, but it does not apply to employers with less than twenty-five em-
ployers or religious employers. Id. The limitations on egg retrievals seem to be reasonable.
286. Id. “The patient and the patient’s spouse must have a history of infertility for 2
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of in vitro fertilization.287 Connecticut limits coverage where there
are two implantations per cycle and only two cycles per lifetime.288
Generally, a woman has approximately a twenty-seven percent
chance of a successful pregnancy using in vitro fertilization.289 Al-
though this number varies with age and other factors, it would seem
to be a good starting point for determining the number of cycles an
insurer should be required to cover. If a woman may need at least
four cycles to sustain a successful pregnancy, then a minimum of four
covered cycles seems reasonable. If she was successful with in vitro
fertilization, two additional cycles does not appear to be unreasonable.
This issue should be addressed during Congressional hearings.
6. Clinic Standards
The Family Building Act requires any treatment to be performed
at a facility that conforms to the standards of the American Society
of Reproductive Medicine (ASRM).290 Several states also have this
requirement, or one that is similar. Maryland requires that the pro-
cedure be performed in a clinic that conforms to the standards of the
ASRM and (or) the American College of Obstetricians and Gynecolo-
gists (ACOG).291 Other states with such restrictions include Connect-
icut, Hawaii, Illinois, New Jersey and Texas.292 This is an excellent
way to add strength to the industry guidelines. There is no need for
the guidelines to impose penalties. The lack of reimbursement should
be enough to discourage physicians from straying from the industry
guidelines.
7. Definition of Infertility
Congressman Weiner and Senator Gillibrand acknowledge that
the primary purpose of in vitro fertilization is to assist infertile
couples. They define infertility as the inability to conceive after one
year of unprotected intercourse or the inability to carry a pregnancy
years or the infertility is associated with one of the following: endometriosis; DES exposure;
blocked or surgically removed fallopian tubes; abnormal male factors contributing to the
infertility.” Id.
287. Id.
288. Id.
289. Richard Paulson, Patient Information: In Vitro Fertilization (IVF), UPTODATE,
http://www.uptodate.com/patients/content/topic.do?topicKey=~zWRuul233/Lo1SR (last
visited Nov. 22, 2010) (citing CTRS. FOR DISEASE CONTROL & PREVENTION ET AL., 2005
ASSISTED REPRODUCTIVE TECHNOLOGY SUCCESS RATES: NATIONAL SUMMARY AND
FERTILITY CLINIC REPORTS 85 (2007), available at http://cdc.gov/art/art2005/).
290. H.R. 697, 111th Cong. (1st Sess. 2009); S. 1258, 111th Cong. (1st Sess. 2009).
291. Insurance Coverage in Your State, supra note 214.
292. Id.
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to live birth.293 This definition does not require a couple to be married,
nor does it make length of time distinctions based on the age of the
mother. Most states that define infertility have language similar to
that used by Weiner and Gillibrand. The definition, however, is not
as liberal as the ASRM; nor is it as restrictive as some state legisla-
tion. A glance at states that have defined infertility results in a web
of confusion. For example, Texas and Hawaii appear to have the most
restrictive state definitions of infertility. In each state the patient
and her spouse shall have had five continuous years of infertility.294
Neither state requires the five year history if the infertility is caused
by one of the following conditions: endometriosis, DES, blocked or
surgically removed fallopian tubes, or oligozoospermia, an abnormal
male factor.295
Maryland and Arkansas require a history of infertility for two
years, but again provide an exception to the two year history if the
infertility is associated with endometriosis, DES, blocked or surgically
removed fallopian tubes, or abnormal male factors.296
New Jersey defines infertility differently based on the age of the
female partner, as does the ASRM. New Jersey defines infertility as
a two year period of unprotected sex when the female partner is under
thirty-five, and one year when she is over thirty-five.297 It also defines
infertility as the inability to carry a baby to term.298 The ASRM de-
fines infertility as the inability to conceive after one year for women
under thirty-five, and six months for women over thirty-five.299
Several states restrict mandated coverage to situations where
a married couple has been unable to conceive after a certain period
of time, or they require that a woman’s egg be fertilized with her hus-
band’s sperm.300 Montana and West Virginia do not define infertility.
The lack of uniformity leaves too much room for confusion and pos-
sible litigation when coverage for services is denied.
Insurance coverage should not be limited to only married couples.
Courts have already determined that coverage for contraceptives
293. H.R. 697, 111th Cong. § 2708(a)(2)(A) (1st Sess. 2009); S. 1258, 111th Cong.
§ 2708(a)(2)(A) (1st Sess. 2009).
294. Insurance Coverage in Your State, supra note 214.
295. Id.
296. Id.
297. Id.
298. Id.
299. Definitions of Infertility and Recurrent Pregnancy Loss, supra note 45.
300. See Insurance Coverage in Your State, supra note 214 (referencing the statutes
of Arkansas, Hawaii, Maryland, Texas and Rhode Island). Rhode Island and Texas re-
strict their definitions of infertility to married individuals. Rhode Island defines infertil-
ity as married individuals who cannot conceive or produce conception during a two year
period. Id.
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applies to both single individuals and married couples. The same
rationale should apply to coverage for in vitro fertilization:
Some countries such as France, Finland, Australia and South
Africa permit single women and lesbian couples access to ART.
While Great Britain’s Human Fertilisation and Embryology Act
of 1990 does not specifically forbid single and lesbian women from
use of ART, its “welfare of the child” provision . . . could allow
health care providers to discriminate against them if they deem
it to be in the child’s welfare.301
. . . .
The American Medical Association has taken the position gener-
ally that providers of health care should not discriminate against
persons due to sexual orientation and has encouraged all medical
practices and physicians to include “sexual orientation, sex or
perceived gender” in any nondiscrimination statements.302
As a result of the non-discriminatory language, coverage for the pro-
cedure should apply to single individuals and those with alternative
lifestyles.
If insurance coverage applies beyond married couples, then
coverage cannot be limited to circumstances where a wife’s eggs are
fertilized with her husband’s sperm. In fact, even if it were limited
only to married couples, the limitation that the wife’s eggs must be
fertilized with the husband’s sperm seems to be too limiting. Several
married individuals require the use of donors in order to have a suc-
cessful pregnancy. These circumstances should also be covered under
the federal mandate. It is also important that the mandate require
insurers to cover the services at the same deductible rates, coinsur-
ance, and out-of-pocket limitations as any other maternity benefit
provisions. Given these minimum requirements, we must address
the associated costs and determine how to balance them.
As infertility may be caused by male or female issues, the defini-
tion should define the term so that it applies to both men and women.
When the cause of infertility is known, a waiting period seems un-
necessary. In such instances, the federal legislation should borrow
those exceptions from Texas, Hawaii and Maryland. If the cause is
unknown, the federal legislation should follow ASRM and distin-
guish between women over thirty-five and under thirty-five. When
a woman under thirty-five has not been able to conceive or produce
conception through natural means for a period of at least a year, the
301. Susan B. Apel, Access to Assisted Reproductive Technologies, 12 MICH. ST. U. J.
MED. & L. 33, 34-35 (2008).
302. Id. at 40.
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procedure should be covered. When a woman thirty-five or older has
not been able to conceive or produce conception through natural means
for a period of at least six months, the procedure should be covered.
Additionally, the federal legislation should keep the inability to carry
a pregnancy to a live birth language in its definition of infertility.
There is no real benefit to forcing an individual to endure multiple
miscarriages before labeling her as infertile.
8. Age Restrictions
The Family Building Act does not limit any insurance mandate
to women of a certain age;303 but should it? It is common knowledge
that fertility declines with age. Older women require more cycles of
in vitro fertilization in order to obtain a pregnancy. For example, data
from the Jones Institute of Reproductive Medicine shows their clinical
pregnancy rate per IVF transfer was 46.4 percent.304 These rates were
directly influenced by the age of the patient. The rate for women
under thirty-five was forty-two percent, women between the ages of
thirty-five and thirty-nine was thirty-six percent, and women over
forty was eighteen percent. In addition to the decrease in fertility,
even healthy older women have a higher chance for a riskier preg-
nancy. As maternal age increases, complications increase, including
hypertension, pre-eclampsia, diabetes, and placenta previa, even in
healthy women.305
In order to begin to balance the costs to insurers, as well as pro-
mote the health and safety of both mother and child, there should
be age restrictions for any mandate. Several states have age limits,
and Congress should look at those for guidance. New Jersey, Rhode
Island, New York, and Connecticut have put age restrictions on their
insurance mandates.306 These states recognized that there must be
a balance between comprehensive coverage and the costs associated
with high risk pregnancies. New Jersey limits coverage for in vitro fer-
tilization to women forty-five or younger.307 Connecticut limits its cov-
erage to individuals under the age of forty.308 Rhode Island’s coverage
is limited to women between twenty-five and forty-two.309 New York
303. H.R. 697, 111th Cong. § 2708 (1st Sess. 2009).
304. In Vitro Fertilization—IVF—Success Rates, THE JONES INST. FOR REPROD. MED.,
http://www.jonesinstitute.org/ivf-success-rates.html [hereinafter In Vitro Fertilization—
IVF—Success Rates] (last visited Nov. 22, 2010).
305. Donor Egg (DE) Program, THE JONES INST. FOR REPROD. MED., http://www.jones
institute.org/donor-egg.html (last visited Nov. 22, 2010).
306. Insurance Coverage in Your State, supra note 214.
307. Id.
308. Id.
309. R.I. GEN. LAWS, § 27-18-30 (1956).
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limits its mandate for infertility coverage to women between age
twenty-one and forty-four.310
Age forty-five seems to be a reasonable age limit. Women are de-
laying childbirth, but the desire for a child must be balanced against
real medical risks to both mother and child. There are genuine medical
concerns that would allow any mandate to limit the age for coverage
without encouraging age discrimination claims.
9. Coverage for Surrogacy and Donors
The use of surrogates, donated eggs, or donated sperm raise con-
troversial issues. Some states avoid the controversy simply by refus-
ing to mandate coverage unless the woman’s egg is fertilized with her
husband’s sperm. Such states include Maryland, Arkansas, Hawaii,
and Texas.311 As discussed earlier, this may be de facto discrimination
against single individuals and individuals with alternative lifestyles.312
The restriction may also deny medically necessary treatment to both
married patients and single patients who may have absent eggs,
poor quality eggs, or eggs that might transmit serious diseases. While
the limitation removes the need to address complex issues associ-
ated with in vitro fertilization, any federal legislation should not have
such restrictive language. The claim that delaying childbirth results
in a need for donor eggs seems to be a myth. Data from the Jones
Institute shows the mean age for donor eggs was twenty-eight.313
There are non-conventional situations that may or may not war-
rant insurance coverage. Any federal mandate should remain silent
on these issues. It would be up to the insurer to determine whether
coverage is warranted. Consider the following example: Geraldine
Wesolowski was a fifty-three-year-old surrogate who carried and
birthed her grandchild. The baby was conceived from her son’s sperm
and his infertile wife’s eggs.314 Should such embryo transplants be
covered under insurance? In this case, there were three attempts
before success. Should it matter whether Geraldine was the surro-
gate for a younger couple, or whether she was pregnant with her own
child? Perhaps these gray areas are where we give the insurers
310. N.Y. INS. LAW § 4303(s)(3)(A) (McKinney 2010); see also N.Y. INS. LAW
§ 4303(s)(3)(E) (McKinney 2010) (expressly excluding in vitro fertilization as a covered
service).
311. Insurance Coverage in Your State, supra note 214.
312. See supra text accompanying note 243.
313. In Vitro Fertilization—IVF—Success Rates, supra note 304.
314. Lindsey Gruson, When ‘Mom’ and ‘Grandma’ Are One and the Same; Fairy Tale
Comes True When Orchard Park Woman Gives Birth to Her Grandchild, N.Y. TIMES,
Feb. 16, 1993, at B1, available at http://www.nytimes.com/1993/02/16/nyregion/when-mom
-grandma-are-one-same-fairy-tale-comes-true-when-orchard-park-woman.html.
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discretion as to whether to cover the service. Such discretion would
also apply to questions regarding what are covered benefits for a
donor. To attempt to address some complex issues in a statute could
create issues that are even more controversial and prevent passage
of the legislation.
10. Cryopreservation
Octomom’s octuplets were the product of cryopreserved (frozen)
embryos. Rather than destroy or donate her unused embryos, she
chose to have her physician transfer them for implantation.315 Some
European countries do not permit the ability to cryopreserve human
embryos. Such an approach would prevent an Octomom situation. The
subject of cryopreservation brings about a host of moral and ethical
issues in this country. Though controversial, there are married cou-
ples who benefit from cryopreservation. For example, suppose one
spouse has been diagnosed with cancer.316 Cryopreservation may be
the couple’s only chance of conceiving a natural child.317 In determin-
ing whether insurance should cover cryopreservation, some issues
to address have to do with whether, medically, the quality of the
embryos do not suffer with cryopreservation. Cryopreservation can
occur at various levels.
The Family Building Act does not address cryopreservation.
There probably will not be bipartisan support for any legislation that
addresses the issue.318
315. Kevin B. O’Reilly, Fertility Doctors Tighten Guidelines in Wake of “Octomom”
Controversy, AM. MED. NEWS, Nov. 9, 2009, http://www.ama-assn.org/amednews/2009
/11/09/prsc1109.htm. The issues associated with cryopreservation are beyond the scope of
this article.
316. Fertility Preservation, UNIV. OF CHI. MED. COLL., http://www.chicagofertility.org
/cryopreservation.htm (last visited Nov. 22, 2010).
317. See, e.g., Celine Dion: Her Story, Her Dream, CHEALTH, http://chealth.canoe.ca
/channel_health_features_details.asp?channel_id=2048&article_id=1201&health_feature
_id=378&relation_id=36843 (last visited Nov. 22, 2010). Celine Dion and her husband Rene
Angelil began trying to conceive when she married in 1994. Id. She was in her twenties and
healthy, but they were not able to become pregnant. Id. After her husband was diagnosed
with cancer in 1999, they feared that Rene’s sperm might be affected by radiation from
chemotherapy. Id. In the process of freezing some of his sperm for later use, they dis-
covered that he had a low sperm count, and that was the cause of the couple’s infertility.
Id. After a procedure called “intracytoplasmic sperm injection,” Dion and Rene used in vitro
fertilization and she gave birth to a son in 2000. Id. At that time, she cryopreserved em-
bryos to use at a later date. Id. In November 2009, Angelil confirmed that, although Dion
was pregnant using those cryopreserved embryos, the pregnancy was unsuccessful. Id.
Nevertheless, after her sixth round of in vitro fertilization, Dion prematurely gave birth to
healthy twin boys on October 23, 2010. See Celine Dion Gives Birth to Twins, CNN.COM,
Oct. 23, 2010, http://articles.cnn.com/2010-10-23/entertainment/celine.dion.twins_1_rene
-angelil-twins-cesarean-section?_s=PM:SHOWBIZ.
318. A future article may compare the United States to other countries where cryo-
preservation is not allowed.
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11. Exhaust Less Costly Methods
The Family Building Act requires that less costly infertility
methods be exhausted before an insurer is required to cover in vitro
fertilization.319 Although several states also use this approach, it may
be more costly than covering in vitro fertilization, and it may also
produce more multi-fetal pregnancies. For example, intrauterine
insemination is a less costly alternative to in vitro fertilization. It is
a process where sperm is injected into a woman’s uterus after hor-
mone shots. It is a cheaper and less effective alternative to in vitro
fertilization. The pregnancy rate is lower than in vitro fertilization,
and there is no control over multi-fetal pregnancies.320 Jon and Kate
Gosselin conceived their sextuplets through intrauterine insemi-
nation (IUI).321 The cost of the intrauterine insemination, though
lower on the front end, was dwarfed by the cost of delivery and care
of sextuplets—costs ultimately paid by the insurer. “[A] recent study
led by Dartmouth Medical School suggested that because IUI often
requires repeated tries, it would ultimately lower both costs and the
risk of large multiple births if many patients avoided the procedure
and moved straight to IVF.” 322 Therefore, any mandate for in vitro
fertilization coverage should not be limited to circumstances where
less costly methods have proven to be unsuccessful.
12. What Not to Do
Federal legislation must provide real benefits to patients.
Louisiana, Ohio, Montana and West Virginia provide models for what
not to do. Louisiana and Ohio have permissive statutory language
that provides no real benefits. Louisiana does not require coverage
for fertility drugs or in vitro fertilization. It merely “[p]rohibits the
exclusion of coverage for the diagnosis and treatment of a correctable
medical condition, solely because the condition results in infertility.”323
Most insurance plans already cover the tests that diagnose infertility.
It is the treatment that is at issue.324 Ohio permits insurers to cover
in vitro fertilization and other ARTs, but the statute does not require
coverage.325 A statute is not necessary to give an insurer permission
for what it can do without a statute.
319. H.R. 697, 111th Cong. § 2708(b)(2)(A)(i) (2009).
320. Saul, supra note 105, at A14.
321. Id.
322. Id.
323. Insurance Coverage in Your State, supra note 214.
324. Id.
325. Id.
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Montana and West Virginia have statutory language that gives
insurers the ability to deny claims, in spite of the statutory mandate.
For example, West Virginia’s statute does not expressly define infer-
tility services, but requires HMOs to cover “basic health care services,
including infertility services, when medically necessary.” 326 The law
does not define infertility and does not mention in vitro fertilization.327
Similarly, Montana’s statute does not define infertility, but it does
require HMOs to cover infertility services as part of basic health care
services.328 These statutes are rather generic and leave room for open
debate (and litigation) about what is and is not covered. The legisla-
tion does not address the current issue of what is the effect of a policy
that does not address the coverage issue. The insurer has room to
deny the claim for what appears to be purely subjective determina-
tions. The Montana and West Virginia statutes may lead to denial
of claims, in spite of the so-called statutory mandate.
C. Garnering Support for the Legislation
Congress does not see the importance of the Family Building Act.
Mr. Weiner has introduced the legislation several times.329 Neither
the House nor the Senate has scheduled hearings or mark-ups on the
legislation. But two things are different during this Congress. First,
the Octomom saga has helped generate media attention about the
issue, and the general population is beginning to understand the im-
portance of the issue. Second, our nation is in the midst of health care
reform. Usually, the committees of jurisdiction—the Committee on
Energy and Commerce, and secondarily the Committees on Education
and Labor, and Oversight and Government Reform—are not inter-
ested in health-related bills. Now, everyone is discussing health care.
Naysayers will argue that in the midst of such a crisis, rather
than concern ourselves with in vitro fertilization, we should be more
concerned about access to insurance for the millions of Americans
who lack health insurance and do not qualify for Medicaid or Medi-
care. These concerns should not be taken lightly. Access to basic care
is more important than infertility treatment for a few. Furthermore,
as there are already significant gaps in coverage, why focus on infer-
tility? It is certainly not the only area of treatment that is excluded
from insurance coverage. Is it justifiable to mandate infertility cover-
age while so many other healthcare needs remain unmet?330
326. Gwen Mayes, Infertility Insurance Laws, 1 INFERTILITY TIMES (Aug. 2003).
327. Insurance Coverage in Your State, supra note 214.
328. Id.
329. The legislation was introduced in both the 109th Congress and the 110th Congress.
330. Strong, supra note 90, at 276.
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To focus on a single issue does not negate the importance of
other issues. In the mid-nineties, Congress mandated that insurers
cover a certain length of hospital stay after childbirth and delivery.331
The reasoning used then can apply to coverage for in vitro fertiliza-
tion today. There was concern that the quality of maternity care was
being sacrificed as a result of managed care. Several states passed
statutes to require insurance companies to “augment” their coverage
of maternity stays.332 Ultimately, federal legislation was enacted to
require a minimum of forty-eight hours of inpatient hospitalization
for a routine vaginal delivery, and ninety-six hours following a routine
cesarean.333 The legislation passed with bipartisan support. Physi-
cians and physicians groups lobbied and testified before Congress.
Medical journals began to discuss the issue. The American Academy
of Pediatrics, the American College of Obstetrics and Gynecology, and
the American Medical Association all supported the legislation.334 Al-
though the legislation was not without naysayers, it quickly addressed
an important issue.
Similarly, such support can be garnered for coverage of in vitro
fertilization. The problem of multi-fetal pregnancies is a public
health concern. A substantial amount of money is spent on reducing
preterm births. If the incidence of preterm births (and associated
risks and costs) can be reduced, and the cost to insurance companies
is negligible, then Congress should pass the legislation.
CONCLUSION
The United States is an “individualistic, market-driven, and
choice-focused” culture.335 Therefore, an additional regulatory agency
will not happen in the near future. Additionally, we will probably
never mandate a specific number of embryos to be transferred. Multi-
fetal pregnancies and the resulting preterm births remain health
issues that affect society. An insurance mandate is the most effective
way to address the public health issue associated with in vitro fer-
tilization without a new regulatory agency and without mandating
that a physician transfer a specific number of embryos.
331. Udom & Betley, supra note 213, at 208.
332. Id.
333. Id.
334. David A. Hyman, What Lessons Should We Learn from Drive-Through Deliveries?,
107 PEDIATRICS 406, 407 (2001). (“[T]he Newborns’ and Mothers’ Health Protection Act
(NMHPA) passed the Senate 98-0, and took effect on January 1, 1998.”). Newborns’ and
Mothers’ Health Protection Act of 1996, Pub. L. No 104-204, 110 Stat. 2935 (1996) (codified
at 29 U.S.C. § 1185, 42 U.S.C. § 300gg-4 to -51 (1996)).
335. Nigel M. De S. Cameron, Pandora’s Progeny: Ethical Issues in Assisted Human
Reproduction, 39 FAM. L.Q. 745, 749 (2005).
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The goal of in vitro fertilization is to produce a healthy single
baby. If an insurance mandate can reduce multi-fetal pregnancies,
not increase costs to insurers, and not negatively affect a clinic’s
overall success rate, then serious thought should be given to passing
such legislation.
As discussed previously, data suggests that in countries and
states with insurance coverage, there is less inclination for physi-
cians to transfer more embryos. This in turn decreases the risk of
multi-fetal pregnancies. America is one of the only developed coun-
tries without such a mandate. If coverage for in vitro fertilization
were nationally mandated, it would provide equal access and care
to all couples who suffer with infertility.336 While the insurance man-
date does not solve all policy issues associated with in vitro fertil-
ization, it does provide some necessary consistency with respect to
services covered. Currently, the treatment is tied to a patient’s place
of residence or financial status.337 The current scheme of state regu-
lation is not effective. Reproductive choice should not be so limited.
336. Jain & Hornstein, supra note 227, at 29.
337. E. Jungheim et al., Family Fertility Fund: Easing the Financial Burden of
Infertility Yields Dramatic Success Rates (Abstract P-675), 86 FERTILITY & STERILITY
S383 (2006).
